
(
  (S
    (NP
      (NP (NNS Mechanisms))
      (VP (VBG Mediating)
        (NP
          (NP (DT the) (JJ Biologic) (NN Activity))
          (PP (IN of)))))))

(
  (S
    (NP
      (NP (JJ Synthetic) (NN Proline))
      (, ,)
      (NP (NN Glycine))
      (, ,)
      (CC and)
      (NP (NN Hydroxyproline)))))

(
  (S
    (NP
      (NP (NNS Polypeptides))
      (PP (IN in)
        (NP (JJ Human) (NNS Neutrophils))))))

(
  (S
    (NP (NN Abstract))))

(
  (S
    (NP
      (NP (DT The) (NN accumulation))
      (PP (IN of)
        (NP (NNS neutrophils)))
      (PP (IN at)
        (NP
          (NP (NNS sites))
          (PP (IN of)
            (NP (NN tissue) (NN injury))))))
    (ADVP (CC or))))

(
  (S
    (NP (NN infection))
    (VP (VBZ is)
      (VP (VBN mediated)
        (PP (IN by)
          (NP
            (NP (JJ chemotactic) (NNS factors))
            (VP (VBN released)
              (PP (IN as)
                (NP
                  (NP (NN part))
                  (PP (IN of)))))))))))

(
  (S
    (S
      (NP (DT the) (JJ inflammatory) (NN process)))
    (. .)))

(
  (S
    (NP
      (NP (DT Some))
      (PP (IN of)
        (NP (DT these) (NNS factors))))
    (VP (VBP are)
      (VP (VBN generated)
        (ADVP (IN as))))))

(
  (S
    (NP
      (NP
        (NP (DT a) (JJ direct) (NN consequence))
        (PP (IN of)
          (NP
            (NP (NN tissue) (NN injury))
            (CC or)
            (NP (NN infection)))))
      (, ,)
      (NP (VBG including)))))

(
  (S
    (NP
      (NP (NN degradation) (NNS fragments))
      (PP (IN of)
        (NP (JJ connective) (NN tissue) (NN collagen)))
      (CC and))))

(
  (S
    (NP
      (NP
        (ADJP
          (ADJP (JJ bacterial-))
          (CC or)
          (ADJP (JJ viral-derived)))
        (NNS peptides))
      (VP (VBG containing)
        (NP (JJ collagen-related))))))

(
  (S
    (NP
      (NP (JJ structural) (NNS motifs))
      (. .))))

(
  (S
    (PP (IN In)
      (NP (DT these) (NNS studies)))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP (JJ biochemical)))))

(
  (S
    (NP
      (NP (NNS mechanisms))
      (VP (VBG mediating)
        (NP
          (NP (DT the) (JJ biologic) (NN activity))
          (PP (IN of)
            (NP (JJ synthetic))))))))

(
  (S
    (NP
      (NP (NNS polypeptides))
      (VP (VBG consisting)
        (PP (IN of)
          (NP
            (NP (JJ repeated) (NNS units))
            (PP (IN of)
              (NP
                (NP (NN proline))
                (PRN (-LRB- -LRB-)
                  (NP (NN Pro))
                  (-RRB- -RRB-)))))))
      (, ,))))

(
  (S
    (NP
      (NP
        (NP (NN glycine))
        (PRN (-LRB- -LRB-)
          (NP (NN Gly))
          (-RRB- -RRB-)))
      (, ,)
      (CC and)
      (NP
        (NP (NN hydroxyproline))
        (PRN (-LRB- -LRB-)
          (NP (NN Hyp))
          (-RRB- -RRB-)))
      (, ,)
      (NP
        (NP (JJ major) (NN amino) (NNS acids))
        (VP (VBN found))))))

(
  (S
    (PP (IN within)
      (NP
        (ADJP
          (ADJP (JJ mammalian))
          (CC and)
          (ADJP (JJ bacterial)))
        (NNS collagens)))
    (. .)))

(
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (FRAG (DT the))))))

(
  (S
    (S
      (NP (NNS peptides))
      (VP (VBD were)
        (NP
          (NP (NNS chemoattractants))
          (PP (IN for)
            (NP (NNS neutrophils))))))
    (. .)))

(
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP (PRP$ their))))

(
  (S
    (NP (JJ chemotactic) (NN potency))
    (VP (VBD was)
      (ADJP (RB directly) (JJ related)
        (PP (TO to)
          (NP (PRP$ their) (NN size)))))
    (CC and)))

(
  (S
    (NP
      (NP (NN composition))
      (. .))))

(
  (S
    (ADVP (RB Thus))
    (, ,)
    (NP
      (NP (DT the) (JJ pentameric) (NNS peptides))
      (PRN (-LRB- -LRB-)
        (NP (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5))))
    (CC and)))

(
  (S (-LRB- -LRB-)
    (NP (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 5))
    (VP (VBD were)
      (ADJP (RBR more) (JJ active))
      (PP (IN in)
        (S
          (VP (VBG inducing)
            (NP (NN chemotaxis) (IN than))))))))

(
  (S
    (NP
      (NP (DT the) (JJ corresponding) (JJ decameric) (NNS peptides))
      (PRN (-LRB- -LRB-)
        (NP (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10))
        (CC and)))))

(
  (S
    (NP
      (NP
        (PRN (-LRB- -LRB-)
          (NP (NN Pro-Hyp-Gly))
          (-RRB- -RRB-))
        (CD 10))
      (. .))))

(
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP
      (NP (DT the) (NN presence))
      (PP (IN of)
        (NP (NN Hyp)))
      (PP (IN in)))))

(
  (S
    (S
      (NP (NNS peptides))
      (VP (VBD reduced)
        (NP (JJ chemotactic) (NN activity))))
    (. .)))

(
  (S
    (NP (DT The) (JJ synthetic) (NNS peptides))))

(
  (S
    (S
      (VP (VBD were)
        (ADVP (RB also))
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB reduce)
                (NP (NN neutrophil) (NN apoptosis))))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (PP (TO to))))

(
  (S
    (NP
      (NP (NN chemotaxis))
      (, ,)
      (NP
        (NP (DT this) (NN activity))
        (VP (VBD was)
          (ADJP (JJ independent)
            (PP (IN of)
              (NP (NN peptide) (NN size) (NN or)))))))))

(
  (S
    (NP
      (NP (NN composition))
      (. .))))

(
  (S
    (NP
      (NP (DT The) (NNS effects))
      (PP (IN of)
        (NP (DT the) (NNS peptides)))
      (PP (IN on)
        (NP (CC both)
          (NN chemotaxis)
          (CC and))))))

(
  (S
    (NP (NN apoptosis))
    (VP (VBD were)
      (VP (VBN blocked)
        (PP (IN by)
          (NP
            (NP (NNS inhibitors))
            (PP (IN of)
              (NP (NN phosphatidylinositol)))))))))

(
  (S
    (S
      (NP
        (NP
          (NP (NN 3-kinase))
          (PRN (-LRB- -LRB-)
            (NP (NN PI3-K))
            (-RRB- -RRB-)))
        (CC and)
        (NP (NN p38) (JJ mitogen-activated) (NN protein) (-LRB- -LRB-) (NN MAP) (-RRB- -RRB-) (NN kinase))))
    (. .)))

(
  (S
    (ADVP (RB However))
    (, ,)
    (NP (RB only)
      (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5))
      (CC and)
      (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10)))
    (VP (VBD induced))))

(
  (S
    (NP
      (NP
        (NP
          (NP (NN expression))
          (PP (IN of)
            (NP (NN PI3-K))))
        (CC and)
        (NP
          (NP (NN phosphorylation))
          (PP (IN of)
            (NP (NN p38) (NN MAP) (NN kinase)))))
      (, ,))))

(
  (S
    (VP (VBG suggesting)
      (NP
        (NP (DT a) (JJ potential) (NN mechanism))
        (VP (VBG underlying)
          (NP (VBN reduced) (NN chemotactic)))))))

(
  (S
    (NP
      (NP (NN activity))
      (PP (IN of)
        (NP (JJ Hyp-containing) (NNS peptides)))
      (. .))))

(
  (S (IN Although)
    (NP
      (NP (NN none))
      (PP (IN of)
        (NP (DT the))))))

(
  (S
    (NP
      (NP (JJ synthetic) (NNS peptides))
      (VP (VBN tested)))
    (VP (VBD had)
      (NP (DT any) (NN effect))
      (PP (IN on)
        (NP (JJ intracellular) (NN calcium))))))

(
  (S
    (NP
      (NP (NN mobilization))
      (, ,)
      (NP
        (NP (DT each) (VBN induced) (JJ nuclear) (NN binding) (NN activity))
        (PP (IN of)
          (NP (DT the)))))))

(
  (S
    (S
      (NP (NN transcription) (NN factor))
      (VP (VBZ NF-κB)))
    (. .)))

(
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP indicate)
      (NP (DT that)))))

(
  (S
    (NP
      (NP (JJ polymeric) (NNS polypeptides))
      (VP (VBG containing)
        (NP (NN Gly-X-Y) (JJ collagen-related))))))

(
  (S
    (NP (JJ structural) (NNS motifs))
    (VP (VBP promote)
      (NP (NN inflammation))
      (PP (IN by)
        (S
          (VP (VBG inducing)
            (NP (NN chemotaxis))))))
    (CC and)))

(
  (S
    (S
      (VP (VBG blocking)
        (NP (NN apoptosis))))
    (. .)))

(
  (S
    (ADVP (RB However))
    (, ,)
    (NP (JJ distinct) (JJ calcium-independent))))

(
  (S
    (S
      (NP (NN signaling) (NNS pathways))
      (VP (VBP appear)
        (S
          (VP (TO to)
            (VP (VB be)
              (VP (VBN involved)
                (PP (IN in)
                  (NP (DT these) (NNS activities)))))))))
    (. .)))

(
  (S
    (NP (NN BACKGROUND))))

(
  (S
    (S
      (NP (DT The) (JJ inflammatory) (NN response))
      (VP (VBZ is)
        (VP (VBN characterized)
          (PP (IN by)
            (NP
              (NP (DT an) (NN accumulation))
              (PP (IN of)
                (NP (NNS neutrophils)))
              (PP (IN at)
                (NP
                  (NP (NNS sites))
                  (PP (IN of)
                    (NP
                      (NP (NN tissue) (NN injury))
                      (CC and)
                      (NP (NN infection)))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Neutrophils))
      (VP (VBP respond)
        (PP (TO to)
          (NP
            (NP (JJ chemotactic) (NNS factors))
            (PP (VBG including)
              (NP
                (NP (JJ connective) (NN tissue) (NN degradation) (NNS products))
                (, ,)
                (NP (NN leukotriene) (NN B4))
                (, ,)
                (CC and)
                (NP
                  (NP (JJ bacterially-derived) (NN formylmethionine-leucine-phenylalanine))
                  (PRN (-LRB- -LRB-)
                    (NP (NN fMLP))
                    (-RRB- -RRB-)))))
            (, ,)
            (VP (VBN released)
              (PP
                (PP (IN from)
                  (NP (JJ damaged) (NN tissue)))
                (CC or)
                (PP (IN by)
                  (NP (JJ invading) (NNS pathogens)))))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (JJ previous) (NNS studies)))
    (NP (PRP we))
    (VP (VBD demonstrated)
      (SBAR (IN that)
        (S
          (S
            (NP
              (NP
                (NP
                  (NP (NN collagenase))
                  (CC or)
                  (NP (NN cyanogen) (NN bromide)))
                (NNS digests))
              (PP (IN of)
                (NP
                  (NP (JJ native) (NN collagen))
                  (, ,)
                  (CONJP (RB as) (RB well) (IN as))
                  (NP
                    (NP (JJ synthetic) (JJ collagen-like) (NNS polypeptides))
                    (VP (VBG containing)
                      (NP
                        (NP
                          (NP (NN glycine))
                          (PRN (-LRB- -LRB-)
                            (NP (NN Gly))
                            (-RRB- -RRB-)))
                        (, ,)
                        (NP
                          (NP (NN proline))
                          (PRN (-LRB- -LRB-)
                            (NP (NN Pro))
                            (-RRB- -RRB-)))
                        (, ,)
                        (CC and)
                        (NP
                          (NP (NN hydroxyproline))
                          (PRN (-LRB- -LRB-)
                            (NP (NN Hyp))
                            (-RRB- -RRB-)))))))))
            (VP (VBP are)
              (NP
                (NP
                  (NP (JJ potent) (NNS chemoattractants))
                  (PP (IN for)
                    (NP (JJ human) (NNS neutrophils))))
                (NP (NN -LSB-1)))))
          (, ,)
          (NP (CD 2) (, ,) (CD 3) (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS polypeptides))
      (ADVP (RB also))
      (VP (VBD activated)
        (NP (NNS macrophages))
        (PP (TO to)
          (NP (NN release) (NN neutrophil) (NNS chemokines)
            (NP (CD -LSB-4)))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ present) (NNS studies))
      (VP (VBD were)
        (VP (VBN aimed)
          (PP (IN at)
            (S
              (VP (VBG analyzing)
                (NP
                  (NP (NNS mechanisms))
                  (VP (VBG mediating)
                    (NP
                      (NP (DT the) (JJ biological) (NN activity))
                      (PP (IN of)
                        (NP
                          (NP (NN collagen) (NN degradation) (NNS products))
                          (VP (VBG using)
                            (NP (JJ synthetic) (NNS polypeptides))
                            (PP (IN as)
                              (NP (DT a) (NN model)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Synthetic) (NNS polypeptides))
      (VP (VBP are)
        (ADJP (JJ similar)
          (PP
            (PP (TO to)
              (NP
                (NP (NN degradation) (NNS products))
                (VP (VBN generated)
                  (PP (IN from)
                    (NP (JJ mammalian) (NN collagen))))))
            (CC and/or)
            (PP (TO to)
              (NP
                (NP (JJ collagen-related) (JJ structural) (NNS motifs))
                (VP (VBN produced)
                  (PP (IN by)
                    (NP
                      (NP (NNS bacteria))
                      (CC and)
                      (NP (NNS viruses) (CD -LSB-5)))))))
            (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN use))
        (PP (IN of)
          (NP
            (NP (JJ synthetic) (NN model) (NNS peptides))
            (PP (IN of)
              (S
                (VP (VBG varying)
                  (NP
                    (NP (NN length))
                    (CC and)
                    (NP (NN composition)))))))))
      (VP (VBD allowed)
        (S
          (NP (PRP us))
          (VP (TO to)
            (VP (VB perform)
              (NP (JJ structure-activity) (NNS studies)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Chemoattractants))
        (PP (JJ such) (IN as)
          (NP
            (NP (NN fMLP))
            (CC and)
            (NP
              (NP (NN interleukin-8))
              (PRN (-LRB- -LRB-)
                (NP (NN IL-8))
                (-RRB- -RRB-))))))
      (VP (VBP initiate)
        (NP (PRP$ their) (JJ biological) (NN activity))
        (PP (IN by)
          (S
            (VP (VBG binding)
              (PP (TO to)
                (NP (JJ specific) (NN cell) (NN surface) (NNS receptors))))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (JJS most) (NNS chemoattractants)))
      (, ,)
      (NP (DT this))
      (VP (VBZ is)
        (VP (VBN followed)
          (PP (IN by)
            (NP
              (NP
                (NP (NN mobilization))
                (PP (IN of)
                  (NP (JJ intracellular) (NN calcium))))
              (, ,)
              (NP
                (NP (NN activation))
                (PP (IN of)
                  (NP (NN protein) (NNS kinases))))
              (, ,)
              (CC and)
              (NP
                (NP
                  (NP (NN translocation))
                  (CC and)
                  (NP (NN binding)))
                (PP (IN of)
                  (NP (NN transcription) (NNS factors)))
                (PP (TO to)
                  (NP
                    (NP (NN consensus) (NNS sequences))
                    (PP (IN in)
                      (NP
                        (NP (NN promoter) (NNS regions))
                        (PP (IN of)
                          (NP
                            (NP (NNS genes))
                            (VP (VBG regulating)
                              (NP
                                (NP (DT the) (JJ inflammatory) (NN response))
                                (PRN
                                  (QP (CD -LSB-6) (, ,) (CD 7) (, ,) (CD 8))
                                  (-RRB- -RSB-))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD speculated)
        (SBAR (IN that)
          (S
            (NP
              (NP (NNS variations))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN activity))
                  (PP (IN of)
                    (NP (DT the) (JJ synthetic) (NNS peptides))))))
            (VP (MD may)
              (VP (VB be)
                (ADJP (JJ related)
                  (PP (TO to)
                    (NP (PRP$ their) (JJ distinct) (NN ability)
                      (S
                        (VP (TO to)
                          (VP (VB activate)
                            (NP (DT these) (VBG signaling) (NNS pathways))))))))))))))
    (. .)))

(
  (S
    (NP (NNS METHODS))))

(
  (S
    (S
      (NP
        (NP
          (NP
            (NP (DT The) (JJ synthetic) (NNS polypeptides))
            (PRN (-LRB- -LRB-)
              (NP (NN Pro-Pro-Gly))
              (-RRB- -RRB-)))
          (NP
            (NP (CD 5))
            (, ,)
            (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10))))
        (, ,)
        (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 5))
        (, ,)
        (CC and)
        (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 10)))
      (VP (VBD were)
        (VP (VBN purchased)
          (PP (IN from)
            (NP (NNS Peptides)
              (NP (NNP International))))
          (PRN (-LRB- -LRB-)
            (NP (NNP Louisville))
            (, ,)
            (NP (NN Ky))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (NN Hanks) (POS ') (JJ balanced) (NN salt) (NN solution))
          (PRN (-LRB- -LRB-)
            (NP (NN HBSS))
            (-RRB- -RRB-)))
        (CC and)
        (NP (NN fMLP)))
      (VP (VBD were)
        (VP (VBN obtained)
          (PP (IN from)
            (NP
              (NP (NN Sigma))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (JJ St) (NN Louis))
                  (, ,)
                  (NP (NN Mo)))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP (NN LY) (CD 294002))
      (VP (VBD was)
        (PP (IN from)
          (NP
            (NP
              (NP (NN Calbiochem))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN La) (NN Jolla))
                  (, ,)
                  (NP (NN Calif)))
                (-RRB- -RRB-)))
            (CC and)
            (NP
              (NP (NN SB) (CD 203580))
              (PP (IN from)
                (NP
                  (NP (NNP Biomol))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP
                        (NP (NNP Plymouth))
                        (VP (VBG Meeting)))
                      (, ,)
                      (NP (NN Pa)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Indo-1) (NN acetoxymethyl) (NN ester))
        (PRN (-LRB- -LRB-)
          (NP (JJ Indo-1) (NN AM))
          (-RRB- -RRB-)))
      (VP (VBD was)
        (VP
          (VP (VBN purchased)
            (PP (IN from)
              (NP
                (NP (JJ Molecular) (NNS Probes))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Eugene) (, ,) (NNP Ore))
                  (-RRB- -RRB-)))))
          (CC and)
          (VP (VBN stored)
            (PP (IN as)
              (NP (DT a) (JJ 1 mM) (NN stock) (NN solution)))
            (PP (IN in)
              (NP (NN dimethylsufoxide)))
            (PP (IN at)
              (NP (NN −20°C)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (JJ Rabbit) (JJ polyclonal) (NNS antibodies))
          (PP (IN against)
            (NP
              (NP (NN NF-κB-p50))
              (, ,)
              (NP (NN NF-κB-p65))
              (, ,)
              (CC and)
              (NP (NN p38) (NN MAP) (NN kinase)))))
        (, ,)
        (CONJP (RB as) (RB well) (IN as))
        (NP (NN horseradish) (JJ peroxidase-) (-LRB- -LRB-) (NN HRP-) (-RRB- -RRB-) (VBN linked) (JJ secondary) (NNS antibodies))
        (, ,))
      (VP (VBD were)
        (PP (IN from)
          (NP (NNP Santa) (NNP Cruz) (NN Biotechnology)))
        (PRN (-LRB- -LRB-)
          (NP (NNP Santa) (NNP Cruz))
          (, ,)
          (NP (NN Calif))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Mouse) (JJ monoclonal) (CD anti-phospho-p38) (NN MAP) (NN kinase) (-LRB- -LRB-) (NN Thr180/Tyr182) (-RRB- -RRB-) (NN antibody))
        (PRN (-LRB- -LRB-)
          (NP (NN IgG1))
          (-RRB- -RRB-)))
      (VP (VBD was)
        (VP (VBN purchased)
          (PP (IN from)
            (NP
              (NP
                (NP (NN Cell) (NN Signaling) (NN Technology))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Beverly))
                  (, ,)
                  (NP (NN Mass))
                  (-RRB- -RRB-)))
              (, ,)
              (CC and)
              (NP (NN mouse) (JJ monoclonal)
                (NP
                  (NP
                    (NP (NN anti-phosphatidylinositol) (NN 3-kinase))
                    (PRN (-LRB- -LRB-)
                      (NP (NN PI3-K))
                      (-RRB- -RRB-)))
                  (PRN (-LRB- -LRB-)
                    (NP (NN p85-subunit-reactive))
                    (-RRB- -RRB-)))
                (NN antibody))))
          (PP (IN from)
            (NP
              (NP (NNP BD) (NNP Biosciences) (NNP PharMingen))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NNP San) (NNP Diego))
                  (, ,)
                  (NP (NN Calif)))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Double-stranded) (NN DNA) (NNS probes))
        (VP (VBN used)
          (PP (IN for)
            (NP
              (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays))
              (PRN (-LRB- -LRB-)
                (NP (NNS EMSAs))
                (-RRB- -RRB-))))))
      (VP (VBD were)
        (VP (VBN obtained)
          (PP (IN from)
            (NP
              (NP (JJ IDT) (NNS Technologies))
              (PRN (-LRB- -LRB-)
                (NP (NNP Coralville) (, ,) (NNP Iowa))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP (JJ FITC-linked) (NN Annexin) (NN V))
      (VP (VBD was)
        (PP (IN from)
          (NP
            (NP
              (NP (NN R) (NN &) (NN D) (NNS Systems))
              (PRN (-LRB- -LRB-)
                (NP (NNP Minneapolis) (, ,) (NNP Minn))
                (-RRB- -RRB-)))
            (, ,)
            (CC and)
            (NP
              (NP (NN propidium) (NN iodide))
              (PP (IN from)
                (NP
                  (NP (NNP Calbiochem))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP San) (NNP Diego))
                      (, ,)
                      (NP (NN Calif)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Human) (NNS neutrophils))
      (VP (VBD were)
        (VP (VBN isolated)
          (PP (IN from)
            (NP (JJ heparinized) (JJ peripheral) (JJ venous) (NN blood)))
          (PP (IN by)
            (NP
              (NP (NN dextran) (NN sedimentation))
              (CC and)
              (NP (NN Ficoll) (NN density) (NN gradient) (NN centrifugation))))
          (PP (IN as)
            (NP
              (ADJP (RB previously) (VBN described))
              (NN -LSB-9) (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS studies))
      (VP (VBD were)
        (ADJP (JJ approved)
          (PP (IN by)
            (NP
              (NP (DT the) (JJ Institutional) (NN Review) (NN Board))
              (PP (IN of)
                (NP
                  (NP (NNP UMDNJ) (NNP Robert) (NNP Wood) (NNP Johnson))
                  (JJ Medical) (NN School))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Migration))
        (PP (IN of)
          (NP (NNS neutrophils)))
        (PP (IN through)
          (NP (NN nucleopore) (NN polycarbonate) (NNS filters))))
      (VP (VBD was)
        (VP (VBN assayed)
          (S
            (VP (VBG using)
              (NP (DT the) (VBN modified) (NN Boyden) (NN chamber) (NN technique) (CD -LSB-10))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (PRP$ our) (NNS studies)))
      (NP (PRP we))
      (VP (VBD used)
        (NP
          (NP (DT a) (JJ 48-well) (NN microchemotaxis) (NN chamber))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NN Neuro) (NN Probe))
              (, ,)
              (NP (NNP Inc) (, ,) (NNP Pleasanton))
              (, ,)
              (NP (NN Calif)))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD Thirty) (NNS microliters))
        (PP (IN of)
          (NP
            (NP (JJ synthetic) (NNS peptides))
            (, ,)
            (NP
              (NP (NN fMLP))
              (PRN (-LRB- -LRB-)
                (NP (CD 5) (NN ×) (NN 10−8 M))
                (-RRB- -RRB-)))
            (, ,)
            (CC or)
            (NP (NN medium) (NN control)))))
      (VP (VBD were)
        (VP (VBN placed)
          (PP (IN in)
            (NP
              (NP (DT each) (NN well))
              (PP (IN of)
                (NP (DT the) (JJR lower) (NN chamber))))))))
    (. .)))

(
  (S
    (S
      (NP (DT A) (JJ 5-μm) (JJ pore-size) (NN filter))
      (VP (VBD was)
        (ADVP (RB then))
        (VP (VBN placed)
          (PP (IN over)
            (NP
              (NP
                (NP (DT the) (NNS wells))
                (CC and)
                (NP (DT the) (JJ upper) (NN chamber)))
              (VP (VBN set)
                (PP (IN into)
                  (NP (NN place)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD Fifty) (NNS microliters))
        (PP (IN of)
          (NP
            (NP (DT a) (NN neutrophil) (NN suspension))
            (PRN (-LRB- -LRB-)
              (NP (CD 1) (NN ×) (NN 105cells))
              (-RRB- -RRB-))))
        (PP (IN in)
          (NP
            (NP
              (NP (NN HBSS))
              (VP (VBG containing)
                (NP
                  (NP
                    (ADJP (CD 0.5) (NN %))
                    (NP
                      (NP (JJ bovine) (NN serum) (NN albumin))
                      (PRN (-LRB- -LRB-)
                        (NP (NN BSA))
                        (-RRB- -RRB-))))
                  (CC and)
                  (NP (NN 2.4 mg/ml) (NNS HEPES)))))
            (, ,)
            (NP (NN pH) (CD 7.2))
            (, ,))))
      (VP (VBD was)
        (VP (VBN added)
          (PP (TO to)
            (NP (DT each) (NN well))))))
    (. .)))

(
  (S
    (S
      (PP (IN After)
        (NP
          (NP (NN incubation))
          (PP (IN for)
            (NP (NNS 45 minutes)))
          (PP (IN at)
            (NP (NN 37°C)))))
      (, ,)
      (NP
        (NP (DT the) (NN filter))
        (VP (VBG containing)
          (NP
            (ADJP
              (ADJP (JJ adhered))
              (, ,)
              (ADJP (VBD migrated)))
            (NNS neutrophils))))
      (VP (VBD was)
        (VP
          (VP (VBN removed))
          (CC and)
          (VP (VBN stained)
            (PP (IN with)
              (NP (NN Wright-Giemsa)))))))
    (. .)))

(
  (S
    (S
      (NP (NN Chemotaxis))
      (VP (VBD was)
        (VP (VBN quantified)
          (PP (IN as)
            (NP
              (NP (DT the) (NN number))
              (PP (IN of)
                (NP
                  (NP (NNS cells))
                  (SBAR
                    (WHNP (WDT that))
                    (S
                      (VP (VBD migrated)
                        (PP (IN through)
                          (NP
                            (NP (DT the) (NN filter))
                            (PP (IN in)
                              (NP (CD 10) (NN oil) (NN immersion) (NNS fields)))))))))))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (DT some) (NNS experiments)))
    (, ,)
    (NP (NNS cells))
    (VP (VBD were)
      (VP (VBN incubated)
        (PP (IN at)
          (NP (JJ room) (NN temperature)))
        (PP (IN with)
          (NP
            (NP
              (NP (NN LY) (CD 294002))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN 50 μM))
                  (, ,)
                  (NP (NN 5 minutes)))
                (-RRB- -RRB-)))
            (CC or)
            (NP
              (NP (NN SB) (CD 203580))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN 30 μM))
                  (, ,)
                  (NP (NN 1 hour)))
                (-RRB- -RRB-)))))
        (ADVP
          (ADVP (RB prior))
          (PP (TO to)
            (NP
              (NP (DT the) (NN analysis))
              (PP (IN of)
                (NP (NN chemotactic) (NN responsiveness))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Indo-1) (NN AM))
      (VP (VBD was)
        (VP (VBN used)
          (S
            (VP (TO to)
              (VP (VB measure)
                (NP (JJ intracellular) (NN calcium) (NN mobilization) (CD -LSB-11)))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP (NNS Neutrophils))
      (VP (VBD were)
        (VP
          (VP (VBN inoculated)
            (PP (IN into)
              (NP
                (NP (NN Nunc) (NN coverglass) (NNS chambers))
                (PRN (-LRB- -LRB-)
                  (NP (CD 2) (NN ×) (NN 106 cells/chamber))
                  (-RRB- -RRB-)))))
          (CC and)
          (VP (VBN allowed)
            (S
              (VP (TO to)
                (VP (VB adhere)
                  (ADJP (JJ overnight)))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Cells))
      (VP (VBD were)
        (VP
          (VP
            (ADVP (RB then))
            (VBN washed)
            (PP (IN with)
              (NP
                (NP (NN HBSS))
                (VP (VBG containing)
                  (NP
                    (ADJP (CD 0.3) (NN %))
                    (NN BSA))))))
          (CC and)
          (VP (VBN incubated)
            (PP (IN in)
              (NP (JJ 1 μM) (JJ Indo-1) (NN AM)))
            (PP (IN at)
              (NP (NN 37°C)))))))
    (. .)))

(
  (S
    (S
      (S
        (PP (IN After)
          (NP (NN 30 minutes)))
        (, ,)
        (NP (DT the) (NNS cells))
        (VP (VBD were)
          (NP (VBN washed)
            (NP (CD three) (NNS times)))))
      (CC and)
      (S
        (NP
          (NP (NN 1 mL))
          (PP (IN of)
            (NP
              (NP (NN HBSS))
              (VP (VBG containing)
                (NP
                  (ADJP (CD 0.3) (NN %))
                  (NN BSA))))))
        (VP (VBD was)
          (VP (VBN added)
            (PP (TO to)
              (NP (DT each) (NN well)))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Intracellular) (NN calcium))
      (VP (VBD was)
        (VP (VBN quantified)
          (PP (IN on)
            (NP
              (NP
                (NP (DT a)
                  (ADJP
                    (NP (NN Meridian) (NN ACAS) (NN 570))
                    (VBN Anchored))
                  (NN Cell) (NN Analysis) (NN System))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Okemos) (, ,) (NNP Mich))
                  (-RRB- -RRB-)))
              (VP (VBN equipped)
                (PP (IN with)
                  (NP
                    (NP (DT an) (NN Innova) (CD 90) (NN 5-W) (NN laser))
                    (VP (VBN adjusted)
                      (PP (TO to)
                        (NP
                          (NP (DT an) (NN output))
                          (PP (IN of)
                            (NP (NN 100 mW))))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP
          (NP (NN measurement))
          (PP (IN of)
            (NP (JJ cellular) (NN fluorescence)))))
      (, ,)
      (NP (NN Indo-1))
      (VP (VBD was)
        (VP (VBN excited)
          (S
            (VP (VBG using)
              (NP
                (NP
                  (NP (DT the) (NN ultraviolet) (NNS lines))
                  (PRN (-LRB- -LRB-)
                    (NP (NN 351–364 nm))
                    (-RRB- -RRB-)))
                (PP (IN of)
                  (NP (DT the) (NN argon) (NN laser)))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Calcium) (NN mobilization))
      (VP (VBD was)
        (VP (VBN quantified)
          (PP (IN by)
            (NP
              (NP (NN scanning) (JJ single) (CD 130) (NN ×) (NN 130 μm) (NNS fields))
              (VP
                (VP (VBG containing)
                  (NP
                    (NP (NN ≥) (CD 15) (NNS cells))
                    (NP
                      (NP (DT every) (NNS 8 seconds))
                      (PP (IN for)
                        (NP
                          (NP (DT a) (NN total))
                          (PP (IN of)
                            (NP (CD 5) (NNS minutes))))))))
                (CC and)
                (VP (VBG collecting)
                  (NP
                    (NP (DT the) (NNS emissions))
                    (PP (IN at)
                      (NP
                        (NP
                          (NP (NN 485 nm))
                          (PRN (-LRB- -LRB-)
                            (NP (JJ calcium-free) (NN Indo-1))
                            (-RRB- -RRB-)))
                        (CC and)
                        (NP
                          (NP (NN 405 nm))
                          (PRN (-LRB- -LRB-)
                            (NP (JJ calcium-saturated) (NN Indo-1))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Data))
      (VP (VBP are)
        (VP (VBN presented)
          (PP (IN as)
            (NP
              (NP (DT the) (NN ratio))
              (PP (IN of)
                (NP (NN emission)))
              (PP (IN at)
                (NP
                  (NP (NN 405 nm))
                  (ADJP (JJ relative)
                    (PP (TO to)
                      (NP (NN 485 nm)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (JJ Synthetic) (NNS peptides))
          (PRN (-LRB- -LRB-)
            (NP (NN 10 nM))
            (-RRB- -RRB-)))
        (CC or)
        (NP
          (NP (NN fMLP))
          (PRN (-LRB- -LRB-)
            (NP (CD 5) (NN ×) (NN 10−8 M))
            (-RRB- -RRB-))))
      (VP (VBD were)
        (VP (VBN added)
          (PP (TO to)
            (NP (DT the) (NNS cells)))
          (PP
            (NP (CD 180) (NNS seconds))
            (IN after)
            (S
              (NP (JJ stable) (NNS baselines))
              (VP (VBD were)
                (VP (VBN established))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Neutrophils))
      (VP (VBD were)
        (VP (VBN incubated)
          (PRN (-LRB- -LRB-)
            (NP (NN 37°C))
            (-RRB- -RRB-))
          (PP (IN with)
            (NP
              (NP (NN medium) (NN control))
              (, ,)
              (NP
                (NP (NN fMLP))
                (PRN (-LRB- -LRB-)
                  (NP (CD 5) (NN ×) (NN 10−8 M))
                  (-RRB- -RRB-)))
              (, ,)
              (CC or)
              (NP
                (NP (NN 10 nM)
                  (PRN (-LRB- -LRB-)
                    (NP (NN Pro-Pro-Gly))
                    (-RRB- -RRB-))
                  (CD 5))
                (, ,)
                (NP
                  (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10))
                  (, ,)
                  (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 5))
                  (, ,)
                  (CC or)
                  (NP
                    (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 10))
                    (PP (IN for)
                      (NP
                        (NP
                          (NP (CD 2) (NNS hours))
                          (PRN (-LRB- -LRB-)
                            (NP (NN PI3-K))
                            (-RRB- -RRB-)))
                        (CC or)
                        (NP
                          (NP (NNS 5 minutes))
                          (PRN (-LRB- -LRB-)
                            (NP (NN p38))
                            (, ,)
                            (NP (NN phospho-p38))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Cells))
      (VP (VBD were)
        (ADVP (RB then))
        (VP (VBN solubilized)
          (PP (IN in)
            (NP
              (NP (NN buffer))
              (VP (VBG containing)
                (NP
                  (NP (CD 50) (NN mM) (NNS HEPES))
                  (, ,)
                  (NP
                    (NP (NN pH) (CD 7.4))
                    (, ,)
                    (NP (NN 10 mM) (NN KCl))
                    (, ,)
                    (NP (NN 1 mM) (NN EDTA))
                    (, ,)
                    (NP (NN 1 mM) (NN DTT))
                    (, ,)
                    (NP (NN 1 μg/mL) (NN pepstatin) (NN A))
                    (, ,)
                    (NP (NN 1 μg/mL) (NN leupeptin))
                    (, ,)
                    (NP
                      (NP (NN 10 μg/mL) (NN soybean) (NN trypsin) (NN inhibitor))
                      (, ,)
                      (NP (NN 10 μg/mL) (NN aprotinin)))
                    (, ,)
                    (CC and)
                    (NP (CD 1) (NN %) (NN Triton) (NN X-100))))))))))
    (. .)))

(
  (S
    (S
      (S
        (PP (IN After)
          (NP
            (NP (NNS 10 minutes))
            (PP (IN in)
              (NP (NN ice)))))
        (, ,)
        (NP (NNS lysates))
        (VP (VBD were)
          (VP (VBN centrifuged)
            (PRN (-LRB- -LRB-)
              (NP (CD 4000) (NN xg))
              (, ,)
              (NP (NNS 5 minutes))
              (-RRB- -RRB-)))))
      (CC and)
      (S
        (NP
          (NP (NN protein) (NNS concentrations))
          (PP (IN in)
            (NP (DT the) (NNS supernatants))))
        (VP (VBD were)
          (VP (VBN quantified)
            (S
              (VP (VBG using)
                (NP
                  (NP (DT a) (NN BCA) (NN Protein) (NN Assay) (NN Kit))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NN Pierce))
                      (, ,)
                      (NP (NNP Rockford))
                      (, ,)
                      (NP (NN Ill)))
                    (-RRB- -RRB-)))
                (PP (IN with)
                  (NP (NN BSA)))
                (PP (IN as)
                  (NP (DT the) (JJ standard)))))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Aliquots))
      (PP (IN of)
        (NP
          (NP (NNS supernatants))
          (VP (VBG containing)
            (NP
              (NP (NN 10 μg))
              (PP (IN of)
                (NP (NN protein))))))))
    (VP (VBD were)
      (VP
        (VP (VBN fractionated)
          (PP (IN on)
            (NP
              (ADJP (CD 7.5) (NN %))
              (NN SDS) (NN polyacrylamide) (NNS gels))))
        (CC and)
        (VP (VBN electroblotted)
          (PP (IN onto)
            (NP
              (NP (JJ 0.45 μm) (NN nitrocellulose) (NN paper))
              (PRN (-LRB- -LRB-)
                (NP (JJ Bio-Rad) (, ,) (NNP Hercules) (, ,) (NNP Calif))
                (-RRB- -RRB-))))
          (PP (IN at)
            (NP
              (NP (NN 250 mA))
              (PP (IN for)
                (NP
                  (NP (NNS 4 hours))
                  (PP (IN in)
                    (NP
                      (NP
                        (NP (DT a) (JJ Mini) (NN Trans-Blot) (JJ Electrophoretic) (NN Transfer) (NN Cell))
                        (PRN (-LRB- -LRB-)
                          (NP (JJ Bio-Rad))
                          (-RRB- -RRB-)))
                      (PP (IN in)
                        (NP
                          (NP
                            (NP (NN 25 mM) (NN Tris))
                            (, ,)
                            (NP (NN pH) (CD 8.3))
                            (, ,)
                            (NP (NN 192 mM) (NN Gly))
                            (, ,)
                            (NP
                              (NP (CD 20) (NN %))
                              (PRN (-LRB- -LRB-)
                                (NP (NN v/v))
                                (-RRB- -RRB-))))
                          (NN methanol))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Blots))
      (VP (VBD were)
        (ADVP (RB then))
        (VP (VBN incubated)
          (PP (IN in)
            (NP
              (NP (DT a) (CD 1) (: :) (CD 250) (NN dilution))
              (PP (IN of)
                (NP
                  (NP (CD anti-phospho-p38) (NN MAP) (NN kinase) (NN antibody))
                  (, ,)
                  (NP (NN anti-p38) (NN MAP) (NN kinase))
                  (, ,)
                  (CC or)
                  (NP (NN anti-PI3-K) (NN antibody)))))))))
    (. .)))

(
  (S
    (PP (IN After)
      (NP (VBG washing)))
    (, ,)
    (NP (DT the) (NNS blots))
    (VP (VBD were)
      (VP (VBN incubated)
        (PP (IN with)
          (NP
            (NP
              (NP
                (NP (NN goat) (NN antimouse) (NN IgG) (-LRB- -LRB-) (CD 1) (: :) (CD 2000) (-RRB- -RRB-))
                (CC or)
                (NP (NN sheep) (NN antirabbit) (NN IgG) (-LRB- -LRB-) (CD 1) (: :) (CD 1000) (-RRB- -RRB-)))
              (JJ HRP-conjugated) (NNS antibodies))
            (PP (IN for)
              (NP (NN 1 hour)))))
        (PP (IN at)
          (NP (JJ room) (NN temperature)))))
    (. .)))

(
  (S
    (S
      (NP (NNS Proteins))
      (VP (VBD were)
        (VP (VBN detected)
          (S
            (VP (VBG using)
              (NP
                (NP (DT a) (NN Renaissance) (NN Western) (NN Blot) (NN Chemiluminescence) (NN Reagent) (NN Plus) (NN kit))
                (PRN (-LRB- -LRB-)
                  (NP (NNP NEN) (NN Life) (NNP Sciences) (, ,) (NNP Boston))
                  (, ,)
                  (NP (NN Mass))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Neutrophils))
      (VP (VBD were)
        (VP
          (VP (VBN washed)
            (PP (IN in)
              (NP (NNS PBS))))
          (, ,)
          (VP (VBN resuspended)
            (PP (IN in)
              (NP
                (NP
                  (NP (NN Dulbecco) (POS 's) (VBN Modified) (JJ Eagle) (POS 's) (NN Medium))
                  (PRN (-LRB- -LRB-)
                    (NP (NN DMEM))
                    (-RRB- -RRB-)))
                (VP (VBG containing)
                  (NP
                    (ADJP (CD 10) (NN %))
                    (JJ fetal) (JJ bovine) (NN serum))))))
          (, ,)
          (CC and)
          (VP (VBN incubated)
            (PP (IN in)
              (NP
                (NP (DT a) (JJ shaking) (NN water) (NN bath))
                (PP (IN at)
                  (NP (NN 37°C)))
                (PP (IN for)
                  (NP
                    (NP (CD 24) (NNS hours))
                    (PP (IN in)
                      (NP
                        (NP (DT the)
                          (NP (NN presence))
                          (CC or)
                          (NP (NN absence)))
                        (PP (IN of)
                          (NP
                            (NP (NNS peptides))
                            (PRN (-LRB- -LRB-)
                              (NP (NN 10 nM))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Cells))
      (VP (VBD were)
        (ADVP (RB then))
        (VP
          (VP (VBN centrifuged))
          (, ,)
          (VP (VBN resuspended)
            (PRN (-LRB- -LRB-)
              (NP (CD 2) (NN ×) (NN 106 cells/mL))
              (-RRB- -RRB-))
            (PP (IN in)
              (NP
                (NP (NN binding) (NN buffer))
                (PRN (-LRB- -LRB-)
                  (NP (CD 10 mM) (NN HEPES/NaOH))
                  (, ,)
                  (NP
                    (NP (NN pH) (CD 7.4))
                    (, ,)
                    (NP (JJ 140 mM) (NN NaCl))
                    (, ,)
                    (NP (NN 2.5 mM) (NN CaCl2)))
                  (-RRB- -RRB-)))))
          (, ,)
          (CC and)
          (VP (VBN incubated)
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NN 15 minutes))
                (, ,)
                (NP (NN room) (NN temperature)))
              (-RRB- -RRB-))
            (PP (IN with)
              (NP
                (NP (NN Annexin) (NN V))
                (CC and)
                (NP (NN propidium) (NN iodide))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Samples))
      (VP (VBD were)
        (VP (VBN analyzed)
          (PP (IN by)
            (NP
              (NP (NN flow) (NN cytometry))
              (PP (IN on)
                (NP
                  (NP (DT a) (NN Coulter) (NN EPICS) (NN Profile) (CD II))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Hialeah) (, ,) (NNP Fla))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (ADJP
            (ADJP (JJ Viable))
            (, ,)
            (ADJP (JJ apoptotic))
            (, ,)
            (CC and)
            (ADJP (JJ necrotic)))
          (NN neutrophil) (NNS populations))
        (VP (VBD were)
          (VP (VBN gated)
            (ADVP (RB electronically)))))
      (CC and)
      (S
        (NP
          (NP (NNS data))
          (VP (VBN analyzed)
            (S
              (VP (VBG using)
                (NP (NN quadrant) (NNS statistics))))))
        (VP (VBN based)
          (PP (IN on)
            (NP
              (NP (JJ relative) (NN Annexin) (NN V))
              (CC and)
              (NP (NN propidium) (NN iodide))
              (NP (NN fluorescence) (NN -LSB-12))))
          (-RRB- -RSB-))))
    (. .)))

(
  (S
    (S
      (VP (TO To)
        (VP (VB prepare)
          (NP (JJ nuclear) (NNS extracts)))))
    (, ,)
    (NP
      (NP (NNS neutrophils))
      (PRN (-LRB- -LRB-)
        (NP (CD 2) (NN ×) (CD 106))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP
        (VP (VBN microcentrifuged)
          (PP (IN for)
            (NP (NN 15 seconds))))
        (CC and)
        (VP
          (ADVP (RB then))
          (VBN resuspended)
          (PP (IN in)
            (NP
              (NP (NN 400 μL))
              (PP (IN of)
                (NP
                  (NP (JJ cold) (NN buffer))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (NP
                        (NP (CD 10 mM) (NN HEPES))
                        (, ,)
                        (NP (NN pH) (CD 7.9)))
                      (, ,)
                      (NP (CD 10 mM) (NN KCl))
                      (, ,)
                      (NP (CD 0.1 mM) (NN EDTA))
                      (, ,)
                      (NP (CD 0.1 mM) (NN EGTA))
                      (, ,)
                      (NP (CD 1 mM) (NN DTT))
                      (, ,)
                      (NP (CD 0.5 mM) (NN PMSF)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN After)
        (NP
          (NP (NNS 15 minutes))
          (PP (IN in)
            (NP (NN ice)))))
      (, ,)
      (S
        (NP
          (NP (NN 25 μL))
          (PP (IN of)
            (NP
              (NP (DT a)
                (ADJP (CD 10) (NN %))
                (NN solution))
              (PP (IN of)
                (NP (NN NP-40))))))
        (VP (VBD was)
          (VP (VBN added))))
      (, ,)
      (CC and)
      (S
        (NP (DT the) (NN sample))
        (VP (VBN mixed)
          (PP (IN on)
            (NP
              (NP (DT a) (NN vortex))
              (PP (IN for)
                (NP (NNS 10 seconds))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NNS lysates))
      (VP (VBD were)
        (ADVP (RB then))
        (VP (VBN centrifuged)
          (PP (IN for)
            (NP
              (NP (NNS 30 seconds))
              (PP (IN in)
                (NP (DT a) (NN microfuge))))))))
    (, ,)
    (NP
      (NP (DT the) (JJ nuclear) (NNS pellets))
      (VP
        (VP (VBN resuspended)
          (PP (IN in)
            (NP
              (NP (NN 50 μL))
              (PP (IN of)
                (NP
                  (NP (JJ ice-cold) (NN buffer))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 20) (NN mM) (NNS HEPES))
                    (, ,)
                    (FRAG
                      (NP (NN pH) (CD 7.9))
                      (, ,)
                      (NP (CD 0.4 M) (NN NaCl))
                      (, ,)
                      (NP (CD 1 mM) (NN EDTA))
                      (, ,)
                      (NP (CD 1 mM) (NN EGTA))
                      (, ,)
                      (NP (CD 1 mM) (NN DTT))
                      (, ,)
                      (NP (CD 1 mM) (NN PMSF)))
                    (-RRB- -RRB-)))))))
        (CC and)
        (VP (VBN placed)
          (PP (IN on)
            (NP
              (NP (DT a) (JJ rocker) (NN platform))
              (PP (IN at)
                (NP (NN 4°C)))
              (PP (IN for)
                (NP (NNS 15 minutes))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT The) (NN sample))
        (VP (VBD was)
          (ADVP (RB then))
          (VP (VBN microcentrifuged)
            (PP (IN for)
              (NP (NN 5 minutes)))
            (PP (IN at)
              (NP (NN 4°C))))))
      (CC and)
      (S
        (NP (DT the) (VBG resulting) (JJ soluble) (JJ nuclear) (NNS extracts))
        (VP (VBD were)
          (VP (VBN collected)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Double-stranded) (NNS probes))
        (VP (VBG containing)
          (NP (DT an) (NN NF-κB) (-LRB- -LRB-) (NN AGTTGAGGGGACCGCCCGCGGCCCGT) (-RRB- -RRB-) (NN consensus) (NN sequence))))
      (VP (VBD were)
        (VP (VBN labeled)
          (PP (IN with)
            (NP (-LRB- -LRB-) (NN γ-32P) (-RRB- -RRB-) (NN -dCTP))))))
    (. .)))

(
  (S
    (PP (IN For)
      (NP (NN binding) (NNS reactions)))
    (, ,)
    (NP
      (NP (JJ nuclear) (NNS extracts))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (NN 50 μg))
          (PP (IN of)
            (NP (NN protein))))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN incubated)
        (PP (IN for)
          (NP (NNS 15 minutes)))
        (PP (IN at)
          (NP (JJ room) (NN temperature)))
        (PP (IN with)
          (NP (JJ labeled) (NN probe)))
        (PP (IN in)
          (NP
            (NP (NN buffer))
            (VP (VBG containing)
              (NP
                (NP (NN 10 mM) (NN Tris-HCl))
                (, ,)
                (NP (NN pH) (CD 7.4))
                (, ,)
                (NP
                  (NP (CD 40 mM) (NN NaCl))
                  (, ,)
                  (NP (CD 10 mM) (NN EDTA)))
                (, ,)
                (NP (NN 1 mM) (NN 2-mercaptoethanol))
                (, ,)
                (NP
                  (ADJP (CD 0.1) (NN %))
                  (NN NP-40))
                (, ,)
                (NP
                  (ADJP (CD 4) (NN %))
                  (NN glycerol))
                (, ,)
                (CC and)
                (NP (NN 0.1 μg/μL) (NN poly))))))))
    (. .)))

(
  (S
    (S
      (PRN (-LRB- -LRB-)
        (NP (NN dI-dC))
        (-RRB- -RRB-))
      (VP (NN poly)))
    (. .)))

(
  (S
    (S
      (S
        (PRN (-LRB- -LRB-)
          (NP (NN dI-dC))
          (-RRB- -RRB-)))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (NNP Amersham) (NNP Pharmacia) (NNP Biotech))
          (, ,)
          (NP (NNP Piscataway) (, ,) (NNP NJ)))
        (-RRB- -RRB-)))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (JJ competitive) (NN binding) (NNS assays)))
      (, ,)
      (NP (JJ nuclear) (NNS extracts))
      (VP (VBD were)
        (VP (VBN incubated)
          (PP (IN with)
            (NP (DT a)
              (ADJP (RB 100-fold) (JJ excess))
              (JJ unlabeled) (NN probe))))))
    (. .)))

(
  (S
    (S
      (NP (NN Supershift) (NNS assays))
      (VP (VBD were)
        (VP (VBN performed)
          (PP (IN by)
            (NP
              (NP (NN incubation))
              (PP (IN of)
                (NP (DT the) (NNS samples)))
              (PP (IN with)
                (NP
                  (NP (JJ polyclonal) (NNS antibodies))
                  (PP (TO to)
                    (NP
                      (NP
                        (NP
                          (NP (NN p50))
                          (CC or)
                          (NP (NN p65)))
                        (PRN (-LRB- -LRB-)
                          (NP (NN 1 μg/60 μL) (NN reaction) (NN volume))
                          (-RRB- -RRB-)))
                      (PP (IN for)
                        (NP
                          (NP (NN 1 hour))
                          (ADJP (JJ prior)
                            (PP (TO to)
                              (NP
                                (NP (DT the) (NN addition))
                                (PP (IN of)
                                  (NP (DT the) (JJ labeled) (NN probe)))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Samples))
      (VP (VBD were)
        (VP (VBN electrophoresed)
          (PP (IN on)
            (NP
              (ADJP (CD 4) (NN %))
              (JJ nondenaturing) (NN polyacrylamide) (NNS gels)))
          (PP (IN in)
            (NP
              (NP
                (NP (NN buffer))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 0.04 M) (NN Tris-acetate))
                    (, ,)
                    (NP (NN 0.001 M) (NN EDTA)))
                  (, ,)
                  (NP (NN pH) (CD 8.0))
                  (-RRB- -RRB-)))
              (PP (IN at)
                (NP (NN 15 V/cm))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Gels))
      (VP (VBD were)
        (ADVP (RB then))
        (ADJP
          (ADJP (JJ dried))
          (CC and)
          (ADJP (JJ autoradiographed)))))
    (. .)))

(
  (S
    (NP (NNS RESULTS))))

(
  (S
    (S
      (S
        (NP (PRP We))
        (VP (VBP have)
          (ADVP (RB previously))
          (VP (VBN demonstrated)
            (SBAR (IN that)
              (S
                (NP
                  (NP (JJ synthetic) (JJ pentameric) (NNS peptides))
                  (VP (VBG consisting)
                    (PP (IN of)
                      (NP
                        (NP (NN Pro))
                        (CC and)
                        (NP
                          (NP
                            (NP (NNP Gly))
                            (, ,)
                            (CC or)
                            (NP (NN Pro)))
                          (, ,)
                          (NP (NNP Hyp))
                          (, ,)
                          (CC and)
                          (NP (NNP Gly)))))))
                (VP (VBP are)
                  (NP
                    (NP
                      (NP (NNS chemoattractants))
                      (PP (IN for)
                        (NP (NNS neutrophils))))
                    (NP
                      (NP (CD -LSB-1))
                      (, ,)
                      (NP (CD 2))
                      (, ,)
                      (NP (CD 3) (-RRB- -RSB-)))))))))
        (. .))
      (S
        (NP (NN Figure) (CD 1))
        (VP (VBZ shows)
          (SBAR (IN that)
            (S
              (NP
                (NP (DT the) (JJ chemotactic) (NN activity))
                (PP (IN of)
                  (NP (DT these) (NNS peptides))))
              (VP (VBZ is)
                (ADJP (NN dose) (JJ related))
                (, ,)
                (S
                  (VP (VBG reaching)
                    (NP (DT a) (NN maximum))
                    (PP (IN at)
                      (NP (NN 10 nM)))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (VBG Increasing)
          (NP
            (NP (DT the) (NN length))
            (PP (IN of)
              (NP
                (NP (DT the) (NNS peptides))
                (PP (IN from)
                  (NP
                    (QP (CD five) (TO to) (CD ten))
                    (JJ repeated) (NNS units))))))))
      (VP (VBD reduced)
        (NP (PRP$ their) (JJ chemotactic) (NN activity))))
    (. .)))

(
  (S
    (S
      (PP (IN At)
        (NP
          (NP (NNS concentrations))
          (PP (IN of)
            (NP
              (NP (CD 1))
              (CC and)
              (NP (CD 10 nM))))))
      (, ,)
      (NP
        (NP (NNS peptides))
        (VP (VBG consisting)
          (PP (IN of)
            (NP
              (NP (NN Pro))
              (, ,)
              (NP (NNP Gly))
              (, ,)
              (CC and)
              (NP (NN Hyp))))))
      (VP (VBD were)
        (ADJP (RBR less) (JJ chemotactic))
        (PP (IN than)
          (NP
            (NP (NNS peptides))
            (VP (VBG consisting)
              (PP (IN of)
                (NP
                  (NP (JJ only) (NN Pro))
                  (CC and)
                  (NP (NNP Gly)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN At)
        (NP (JJ optimal) (NNS concentrations)))
      (, ,)
      (NP
        (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5))
        (, ,)
        (NP
          (NP (DT the) (RBS most) (JJ potent))
          (PP (IN of)
            (NP (DT the) (JJ synthetic) (NNS peptides))))
        (, ,))
      (VP (VBD was)
        (ADJP
          (NP
            (QP (RB approximately) (CD 60))
            (NN %))
          (RBR less) (JJ active)
          (PP (IN than)
            (NP (NN fMLP))))
        (PP (IN in)
          (S
            (VP (VBG inducing)
              (NP (NN chemotaxis))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (NNS data))
                  (VP (RB not) (VBN shown)))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP (VBN Activated) (NNS neutrophils))
      (VP (VBP are)
        (VP (VBN cleared)
          (PP (IN from)
            (NP (JJ inflamed) (NNS sites)))
          (PP (IN by)
            (NP
              (NP (DT the) (NN process))
              (PP (IN of)
                (NP (NN apoptosis)))))
          (, ,)
          (S
            (VP (VBN followed)
              (PP (IN by)
                (NP (NN macrophage) (NN phagocytosis))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (VP (VBZ leads)
        (PP (TO to)
          (NP
            (NP (NN resolution))
            (CONJP (RB rather) (IN than))
            (NP
              (NP (NN persistence))
              (PP (IN of)
                (NP (NN tissue) (NN injury))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Chemoattractants))
        (PP (JJ such) (IN as)
          (NP (NN fMLP))))
      (VP (VBP promote)
        (NP (NN inflammation))
        (PP (IN by)
          (S
            (VP
              (VP (VBG activating)
                (NP (NNS neutrophils)))
              (CC and)
              (VP (VBG prolonging)
                (NP
                  (NP (DT the) (NN survival))
                  (PP (IN of)
                    (NP (DT these) (NNS cells)))
                  (PP (IN in)
                    (NP (NNS tissues))))
                (PP (IN by)
                  (S
                    (VP (VBG blocking)
                      (NP (NN apoptosis) (CD -LSB-13) (-RRB- -RSB-)))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (JJ further) (NNS studies)))
      (, ,)
      (NP (PRP we))
      (VP (VBD analyzed)
        (NP
          (NP (DT the) (NNS effects))
          (PP (IN of)
            (NP (JJ synthetic) (JJ polymeric) (NNS peptides)))
          (PP (IN on)
            (NP (NN neutrophil) (NN apoptosis))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD One))
        (PP (IN of)
          (NP
            (NP (DT the) (JJS earliest) (NNS signs))
            (PP (IN of)
              (NP (NN apoptosis))))))
      (VP (VBZ is)
        (NP
          (NP (NN translocation))
          (PP (IN of)
            (NP
              (NP (NN phosphatidylserine))
              (PRN (-LRB- -LRB-)
                (NP (NN PS))
                (-RRB- -RRB-))))
          (PP (IN from)
            (NP (DT the) (JJ inner)))
          (PP (TO to)
            (NP
              (NP (DT the) (JJ outer) (NN surface))
              (PP (IN of)
                (NP (DT the) (NN plasma) (NN membrane)))))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (MD can)
                (VP (VB be)
                  (VP (VBN detected)
                    (PP (IN by)
                      (NP
                        (NP (NN Annexin) (NN V))
                        (VP (VBG binding)
                          (NP (CD -LSB-14) (-RRB- -RSB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (QP (RB Approximately) (CD 30))
          (NN %))
        (PP (IN of)
          (NP (NNS neutrophils))))
      (VP (VBD was)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB undergo)
                (NP (JJ spontaneous) (NN apoptosis))
                (PP (IN after)
                  (NP
                    (NP (NNS 24 hours))
                    (PP (IN in)
                      (NP (NN culture)))))
                (PRN (-LRB- -LRB-)
                  (NP (NN Figure) (CD 2))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN activity))
      (VP (VBD was)
        (ADVP (RB significantly))
        (VP (VBN reduced)
          (PP (IN in)
            (NP
              (NP (DT the) (NN presence))
              (PP (IN of)
                (NP (DT the) (NNS polypeptides))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS effects))
        (PP (IN of)
          (NP (DT the) (JJ synthetic) (NNS peptides))))
      (VP (VBD were)
        (ADJP (JJ similar)
          (PP (TO to)
            (NP (NN fMLP))))))
    (. .)))

(
  (S
    (S
      (PP (IN In) (NN contrast) (TO to)
        (NP (NN chemotaxis)))
      (, ,)
      (NP (DT no) (NNS differences))
      (VP (VBD were)
        (VP (VBN noted)
          (PP (IN in)
            (NP
              (NP (DT the) (JJ antiapoptotic) (NN activity))
              (PP (IN of)
                (NP (JJ collagen-like) (NNS peptides)))
              (PP (IN in)
                (NP
                  (NP (NNS terms))
                  (PP (IN of)
                    (NP (PRP$ their)
                      (NP (NN size))
                      (CC or)
                      (NP (NN composition)))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB next))
      (VP (VBD investigated)
        (NP
          (NP (JJ potential) (JJ biochemical) (NN signaling) (NNS pathways))
          (VP (VBG mediating)
            (NP
              (NP (DT the) (JJ biologic) (NN activity))
              (PP (IN of)
                (NP (DT these) (NNS peptides)))
              (PP (IN in)
                (NP (NNS neutrophils))))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (JJ comparative) (NNS purposes)))
      (, ,)
      (NP (PRP we))
      (ADVP (RB also))
      (VP (VBD evaluated)
        (NP
          (NP (DT the) (NN response))
          (PP (IN of)
            (NP (DT the) (NNS cells)))
          (PP (TO to)
            (NP (NN fMLP))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Treatment))
        (PP (IN of)
          (NP (NNS neutrophils)))
        (PP (IN with)
          (NP (NN fMLP))))
      (VP (VBD caused)
        (NP
          (NP (DT a)
            (ADJP
              (ADJP (JJ rapid))
              (CC and)
              (ADJP (JJ transient)))
            (NN increase))
          (PP (IN in)
            (NP (JJ intracellular) (NN calcium)))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBD was)
                (ADJP (JJ evident)
                  (PP (IN within)
                    (NP
                      (NP (NN 30 seconds))
                      (PRN (-LRB- -LRB-)
                        (NP (NN Figure) (CD 3))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN contrast)))
      (, ,)
      (NP
        (NP (NN none))
        (PP (IN of)
          (NP (DT the) (JJ synthetic) (NNS polypeptides))))
      (VP (VBD induced)
        (NP (NN calcium) (NN mobilization))
        (PP (IN in)
          (NP (NNS neutrophils)))))
    (. .)))

(
  (S
    (S
      (NP (NN PI3-K))
      (VP
        (VP (VBZ catalyzes)
          (NP
            (NP (DT the) (NN formation))
            (PP (IN of)
              (NP (NN phosphatidylinositol) (NN 3,4,5-triphosphate)))))
        (CC and)
        (VP (VBZ plays)
          (NP (DT a) (JJ key) (NN role))
          (PP (IN in)
            (NP
              (NP (NN neutrophil) (NN activation))
              (CC and)
              (NP (NN chemotaxis) (CD -LSB-15) (, ,) (CD 16) (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Low) (NNS levels))
        (PP (IN of)
          (NP (NN PI3-K) (NN protein))))
      (VP (VBD were)
        (ADJP (JJ detectable))
        (PP (IN in)
          (NP (JJ unstimulated) (NNS neutrophils)))
        (PRN (-LRB- -LRB-)
          (NP (NN Figure) (NN 4a))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Treatment))
        (PP (IN of)
          (NP (DT the) (NNS cells)))
        (PP (IN with)
          (NP
            (NP (JJ pentameric) (NNS peptides))
            (VP (VBG consisting)
              (PP (IN of)
                (NP
                  (NP (NN Pro))
                  (CC and)
                  (NP (NN Gly))))))))
      (VP (VBD resulted)
        (PP (IN in)
          (NP
            (NP (DT a) (JJ twofold) (NN increase))
            (PP (IN in)
              (NP (NN PI3-K)))))))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (VP
        (VP (VBD was)
          (ADJP (JJ evident)
            (PP (IN after)
              (NP (NN 2 hours)))))
        (CC and)
        (VP (VBD was)
          (ADJP (JJ similar)
            (PP (TO to)
              (NP
                (NP (DT the) (NN response))
                (VP (VBN observed)
                  (PP (IN with)
                    (NP (NN fMLP))))))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP
      (NP (DT the) (JJ pentameric) (NN peptide))
      (VP
        (VP (VBG containing)
          (NP
            (NP (NN Hyp))
            (VP (VBD had)
              (NP (DT no) (NN effect))
              (PP (IN on)
                (NP (NN PI3-K))))))
        (, ,)
        (CC and)
        (VP (VBG increasing)
          (NP
            (NP (DT the) (NN length))
            (PP (IN of)
              (NP
                (NP (DT the) (NNS peptides))
                (PP (IN from)
                  (NP
                    (QP (CD 5) (TO to) (CD 10))
                    (VBN repeated) (NNS units)))))))))
    (VP (VBD did) (RB not)
      (VP (VB alter)
        (NP
          (NP (DT the) (NN quantity))
          (PP (IN of)
            (NP
              (NP (NN PI3-K))
              (VP (VBN detected)))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB analyze)
            (NP
              (NP (DT the) (NN role))
              (PP (IN of)
                (NP (NN PI3-K)))
              (PP (IN in)
                (NP
                  (NP (NN collagen) (JJ peptide-induced) (NN chemotaxis))
                  (CC and)
                  (NP (NN apoptosis))))))))
      (, ,)
      (NP (NNS cells))
      (VP (VBD were)
        (VP (VBN treated)
          (PP (IN with)
            (NP (NN LY) (NN 294002) (CD -LSB-17)))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN PI3-K) (NN inhibitor))
      (VP (VBD was)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB reduce)
                (NP
                  (NP (NN chemotaxis))
                  (VP (VBN induced)
                    (PP (IN by)
                      (NP
                        (NP (NN fMLP))
                        (, ,)
                        (NP
                          (NP
                            (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5))
                            (CC and)
                            (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10)))
                          (, ,)
                          (ADVP (RB as) (RB well)
                            (PP (IN as)
                              (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 5)))))
                        (, ,)
                        (CC and)
                        (-LRB- -LRB-)
                        (NP (NN Pro-Hyp-Gly))
                        (-RRB- -RRB-) (CD 10)))
                    (PP (IN by)
                      (NP (CD 50) (NN %)))
                    (PRN (-LRB- -LRB-)
                      (NP (NN Figure) (NN 1b))
                      (, ,)
                      (S
                        (NP (NNS data))
                        (VP (RB not) (VBN shown)))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT No) (JJ major) (NNS differences))
      (VP (VBD were)
        (VP (VBN noted)
          (PP (IN in)
            (NP
              (NP (DT the) (NN sensitivity))
              (PP (IN of)
                (NP (DT the) (NNS peptides)))
              (PP (TO to)
                (NP (DT the) (NN PI3-K) (NN inhibitor))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Similarly))
      (, ,)
      (NP (NN LY) (CD 294002))
      (VP (VBD was)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB block)
                (NP
                  (NP (DT the) (JJ inhibitory) (NNS effects))
                  (PP (IN of)
                    (NP (CC both)
                      (NP (NN fMLP))
                      (CC and)
                      (NP (JJ synthetic) (NNS peptides))))
                  (PP (IN on)
                    (NP (NN apoptosis))))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN As)
        (S
          (VP (VBN observed)
            (PP (IN with)
              (NP (NN chemotaxis))))))
      (, ,)
      (NP (DT no) (NNS differences))
      (VP (VBD were)
        (VP (VBN observed)
          (PP (IN in)
            (NP
              (NP (DT the) (NN sensitivity))
              (PP (IN of)
                (NP
                  (NP (DT the) (JJ antiapoptotic) (NNS effects))
                  (PP (IN of)
                    (NP (DT the) (NNS peptides)))))
              (PP (TO to)
                (NP (NN PI3-K) (NN inhibition)))))
          (PRN (-LRB- -LRB-)
            (NP (NN Figure) (CD 2))
            (, ,)
            (S
              (NP (NNS data))
              (VP (RB not) (VBN shown)))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP
          (NP (DT the) (NN absence))
          (PP (IN of)
            (NP (DT these) (NNS peptides)))))
      (, ,)
      (NP (NN LY) (CD 294002))
      (VP (VBD had)
        (NP (DT no) (NN effect))
        (PP (IN on)
          (NP
            (NP (NN chemotaxis))
            (CC or)
            (NP (NN apoptosis))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Recent) (NNS studies))
      (VP (VBP have)
        (VP (VBN implicated)
          (NP (NN MAP) (NNS kinases))
          (PP
            (PP (IN in)
              (NP (JJ chemoattractant-induced) (NN signaling)))
            (CC and)
            (PP (IN in)
              (NP
                (NP (NN PI3-K) (NN activation))
                (PP (IN in)
                  (NP (NNS neutrophils)
                    (QP (CD -LSB-18) (, ,) (CD 19) (, ,) (CD 20))))))
            (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD found)
        (SBAR (IN that)
          (S
            (NP (JJ untreated) (NNS neutrophils))
            (VP (VBD expressed)
              (NP
                (NP (RB relatively) (JJ large) (NNS quantities))
                (PP (IN of)
                  (NP
                    (NP (JJ total)
                      (NP (NN p38) (NN MAP) (NN kinase))
                      (NN protein))
                    (PRN (-LRB- -LRB-)
                      (NP (NN Figure) (NN 4b))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Expression))
        (PP (IN of)
          (NP (DT this) (NN protein))))
      (VP (VBD was)
        (ADJP (JJ unaltered)
          (PP
            (PP (IN by)
              (NP (NN fMLP)))
            (CC or)
            (PP (IN by)
              (NP (JJ synthetic) (NNS polypeptides)))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (S
      (S
        (NP
          (NP
            (ADJP (RB only) (JJ low))
            (NNS levels))
          (PP (IN of)
            (NP (NN phospho-p38) (NN MAP) (NN kinase))))
        (VP (VBD were)
          (VP (VBN detected)
            (PP (IN in)
              (NP (JJ unstimulated) (NNS neutrophils))))))
      (, ,)
      (CC and)
      (S
        (NP (DT this))
        (VP (VBD was)
          (ADVP (RB markedly))
          (VP (VBN increased)
            (PP (IN in)
              (NP
                (NP (NN response))
                (PP (TO to)
                  (NP (NN fMLP)))))
            (, ,)
            (ADVP (RB as) (RB well)
              (PP (IN as)
                (NP
                  (NP
                    (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5))
                    (CC and)
                    (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10)))
                  (PRN (-LRB- -LRB-)
                    (NP (NN Figure) (NN 4c))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS effects))
        (PP (IN of)
          (NP (DT these) (NNS peptides)))
        (PP (IN on)
          (NP (NN phospho-p38) (NN expression))))
      (VP (VBD were)
        (ADJP (JJ rapid))
        (, ,)
        (S
          (VP
            (VP (VBG peaking)
              (NP
                (NP (CD 5) (NNS minutes))
                (PP (IN after)
                  (NP (NN treatment)))))
            (CC and)
            (VP (VBG persisting)
              (PP (IN for)
                (NP
                  (NP
                    (ADJP (IN at) (JJS least))
                    (NNS 20 minutes))
                  (PRN (-LRB- -LRB-)
                    (NP (NN Figure) (CD 4d))
                    (, ,)
                    (S
                      (NP (NNS data))
                      (VP (RB not) (VBN shown)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Treatment))
        (PP (IN of)
          (NP (NNS neutrophils)))
        (PP (IN with)
          (NP
            (NP (NNS peptides))
            (VP (VBG containing)
              (NP (NN Hyp))))))
      (VP (VBD had)
        (NP (DT no) (JJ significant) (NN effect))
        (PP (IN on)
          (NP
            (NP (NN phospho-p38) (NN protein) (NN expression))
            (PRN (-LRB- -LRB-)
              (NP (NN Figure) (NN 4c))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Pretreatment))
        (PP (IN of)
          (NP (DT the) (NNS cells)))
        (PP (IN with)
          (NP
            (NP (NN SB) (CD 203580))
            (, ,)
            (NP (DT a) (NN p38) (NN MAP) (NN kinase) (NN inhibitor) (CD -LSB-21) (-RRB- -RSB-))
            (, ,))))
      (VP (VBD was)
        (VP (VBN found)
          (S
            (VP (TO to)
              (ADVP (RB significantly))
              (VP (VB reduce)
                (NP
                  (NP (NN chemotaxis))
                  (VP (VBN induced)
                    (PP (IN by)
                      (NP
                        (NP
                          (PRN (-LRB- -LRB-)
                            (NP (NN Pro-Pro-Gly))
                            (-RRB- -RRB-))
                          (NP (CD 5))
                          (CC and)
                          (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10)))
                        (, ,)
                        (ADVP (RB as) (RB well)
                          (PP (IN as)
                            (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 5))))
                        (, ,)
                        (CC and)
                        (NP
                          (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 10))
                          (PRN (-LRB- -LRB-)
                            (NP (NN Figure) (NN 1b))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Similarly))
      (, ,)
      (NP (NN SB) (CD 203580))
      (VP (VBD blocked)
        (NP
          (NP (DT the) (NNS effects))
          (PP (IN of)
            (NP
              (NP (NN fMLP))
              (CC and)
              (NP (JJ synthetic) (NNS peptides))))
          (PP (IN on)
            (NP (NN apoptosis))))
        (, ,)
        (S
          (VP (VBG indicating)
            (SBAR (IN that)
              (S
                (NP (DT this) (NN response))
                (VP (VBZ is)
                  (ADVP (RB also))
                  (ADJP
                    (ADJP (NN p38) (NN MAP) (JJ kinase-dependent))
                    (PRN (-LRB- -LRB-)
                      (NP (NN Figure) (CD 2))
                      (, ,)
                      (S
                        (NP (NNS data))
                        (VP (RB not) (VBN shown)))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The)
        (NP (NN transcription) (NN factor))
        (NP (NN NF-κB)))
      (VP (VBZ is)
        (VP (VBN known)
          (S
            (VP (TO to)
              (VP (VB be)
                (VP (VBN activated)
                  (PP (IN by)
                    (NP (NNS chemoattractants)))
                  (PP (IN through)
                    (NP (NN MAP) (NNS kinases) (CD -LSB-22) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD found)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT each))
              (PP (IN of)
                (NP (DT the) (JJ synthetic) (NNS peptides))))
            (, ,)
            (PP (IN like)
              (NP (NN fMLP)))
            (, ,)
            (VP (VBD induced)
              (NP
                (NP (JJ nuclear) (NN binding))
                (PP (IN of)
                  (NP
                    (NP (NN NF-κB))
                    (PRN (-LRB- -LRB-)
                      (NP (NN Figure) (CD 5))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN response))
      (VP (VBD was)
        (ADJP (JJ independent)
          (PP (IN of)
            (NP
              (NP (NN peptide) (NN length))
              (CC or)
              (NP (NN composition)))))))
    (. .)))

(
  (S
    (S
      (NP (NN Supershift) (NNS assays))
      (VP (VBD revealed)
        (SBAR (IN that)
          (S
            (NP (DT the) (JJ NF-κB) (NN complex))
            (VP (VBD contained)
              (NP (CC both)
                (NP (NN p50))
                (CC and)
                (NP (NN p65)))
              (PRN (-LRB- -LRB-)
                (ADVP (RB not))
                (VP (VBN shown))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Preincubation))
        (PP (IN of)
          (NP (JJ nuclear) (NNS extracts)))
        (PP (IN with)
          (NP (JJ excess) (JJ unlabeled) (NN probe))))
      (ADVP (RB competitively))
      (VP (VBD reduced)
        (NP
          (NP (NN binding))
          (PP (IN of)
            (NP (DT the) (JJ labeled) (NN probe))))
        (, ,)
        (S
          (VP (VBG demonstrating)
            (NP (PRP$ its) (NN specificity))))))
    (. .)))

(
  (S
    (NP (NN DISCUSSION))))

(
  (S
    (S
      (NP
        (NP (NN Neutrophil) (NN chemotaxis))
        (CC and)
        (NP (NN survival)))
      (VP (VBP are)
        (VP (VBN regulated)
          (PP (IN by)
            (NP
              (NP (JJ inflammatory) (NNS mediators))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBP are)
                    (ADJP (JJ present))
                    (PP (IN at)
                      (NP
                        (NP (NNS sites))
                        (PP (IN of)
                          (NP
                            (NP (NN infection))
                            (CC or)
                            (NP (NN injury))))))))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Whereas)
        (S
          (NP (JJ proinflammatory) (NNS mediators))
          (VP
            (VP (VBP promote)
              (NP (NN chemotaxis)))
            (CC and)
            (VP (VBP block)
              (NP (NN apoptosis))))))
      (, ,)
      (NP (JJ antiinflammatory) (NNS cytokines))
      (VP
        (VP (VBP are)
          (ADJP (JJ proapoptotic)))
        (CC and)
        (VP (VB abrogate)
          (NP (DT the) (JJ chemotactic) (NN response)))))
    (. .)))

(
  (S
    (NP
      (NP (JJ Coordinate) (NN regulation))
      (PP (IN of)
        (NP
          (NP (NN chemotaxis))
          (CC and)
          (NP (NN survival)))))
    (VP (VBZ allows)
      (PP (IN for)
        (NP
          (NP (DT the) (NN persistence))
          (PP (IN of)
            (NP (NNS neutrophils)))
          (PP (IN at)
            (NP
              (NP
                (NP (NNS sites))
                (PP (IN of)
                  (NP (NN injury))))
              (, ,)
              (CONJP (RB as) (RB well) (IN as))
              (NP
                (NP (JJ effective) (NN termination))
                (PP (IN of)
                  (NP (DT the) (JJ inflammatory) (NN response) (NN -LSB-23))))))
          (-RRB- -RSB-))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ present) (NNS studies))
      (VP (VBP demonstrate)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ synthetic) (NNS peptides))
              (VP (VBG containing)
                (NP (JJ collagen-like) (JJ structural) (NNS motifs))))
            (VP
              (VP (VBP induce)
                (NP (NN chemotaxis)))
              (CC and)
              (VP (VBP reduce)
                (NP
                  (NP (NN apoptosis))
                  (PP (IN in)
                    (NP (NNS neutrophils))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS results))
      (VP (VBP are)
        (ADJP (JJ consistent)
          (PP (IN with)
            (NP
              (NP (DT a) (JJ proinflammatory) (NN role))
              (PP (IN of)
                (NP (DT these) (NNS peptides))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (VP (VBZ is)
        (VP (VBN supported)
          (PP (IN by)
            (NP (NNS reports)
              (SBAR (IN that)
                (S
                  (NP (JJ synthetic) (JJ collagen-like) (NNS peptides))
                  (ADVP (RB also))
                  (VP (VBP stimulate)
                    (NP
                      (NP
                        (NP (JJ oxidative) (NN metabolism))
                        (CC and)
                        (NP (NN macrophage) (NN release)))
                      (PP (IN of)
                        (NP (NN neutrophil) (NNS chemokines)
                          (NP
                            (NP (CD -LSB-4))
                            (PRN (, ,)
                              (NP (CD 24))
                              (-RRB- -RSB-))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Tissue) (NN injury))
      (VP (VBZ is)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (NN breakdown))
              (PP (IN of)
                (NP (JJ interstitial) (JJ connective) (NN tissue))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (NNS findings)
        (SBAR (IN that)
          (S
            (NP
              (NP (NNS peptides))
              (VP (VBG containing)
                (NP (JJ collagen-like) (JJ structural) (NNS motifs))))
            (VP (VBP exhibit)
              (NP (JJ proinflammatory) (NN activity))))))
      (VP (VBZ suggests)
        (SBAR (IN that)
          (S
            (NP (PRP they))
            (VP (MD may)
              (VP (VB play)
                (NP (DT a) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG amplifying)
                      (NP
                        (NP (JJ acute) (JJ immunological) (NNS responses))
                        (PP (TO to)
                          (NP
                            (NP (NN infection))
                            (CC or)
                            (NP (NN injury))))))))))))))
    (. .)))

(
  (S
    (S
      (ADJP (JJ Consistent)
        (PP (IN with)
          (NP (JJ previous) (NNS studies)
            (NP
              (NP (NN -LSB-2))
              (PRN (, ,)
                (NP (CD 3))
                (-RRB- -RSB-)))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (JJ chemotactic) (NN activity))
            (PP (IN of)
              (NP (DT the) (JJ synthetic) (NNS polypeptides))))
          (VP (VBD was)
            (ADJP (RB directly) (JJ related)
              (PP (TO to)
                (NP (PRP$ their)
                  (NP (NN size))
                  (CC and)
                  (NP (NN composition)))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (, ,)
      (NP
        (NP (JJR larger) (NNS peptides))
        (VP (VBG containing)
          (NP (CD ten) (JJ repeated) (NNS subunits))))
      (VP (VBD were)
        (ADJP (RBR less) (JJ active))
        (PP (IN than)
          (NP
            (NP (DT those))
            (VP (VBG containing)
              (NP (CD five) (NNS subunits)))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Moreover))
      (, ,)
      (NP
        (NP (NNS peptides))
        (VP (VBG consisting)
          (PP (IN of)
            (NP
              (NP (NN Pro))
              (, ,)
              (NP (NNP Gly))
              (, ,)
              (CC and)
              (NP (NN Hyp))))))
      (VP (VBD were)
        (ADJP (RBR less) (JJ chemotactic))
        (PP (IN than)
          (NP
            (NP (NNS peptides))
            (VP (VBG consisting)
              (PP (IN of)
                (NP
                  (NP (JJ only) (NN Pro))
                  (CC and)
                  (NP (NNP Gly)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN contrast)))
      (, ,)
      (SBAR (IN although)
        (S
          (NP
            (NP (DT each))
            (PP (IN of)
              (NP (DT the) (NNS peptides))))
          (ADVP (RB markedly))
          (VP (VBD reduced)
            (NP (NN neutrophil) (NN apoptosis)))))
      (, ,)
      (NP (DT these) (NNS effects))
      (VP (VBD were)
        (ADJP (JJ independent)
          (PP (IN of)
            (NP
              (NP (NN peptide) (NN size))
              (CC or)
              (NP (NN structure)))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS data))
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN collagen) (JJ peptide-induced) (NN chemotaxis))
              (CC and)
              (NP (NN apoptosis)))
            (VP (VBP involve)
              (NP
                (NP (JJ distinct) (NNS receptors))
                (CC and/or)
                (NP (NN signaling) (NNS mechanisms))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD One) (JJ early) (NN step))
        (PP (IN in)
          (NP
            (NP (DT the) (NN signaling) (NN pathway))
            (VP (VBN induced)
              (PP (IN by)
                (NP (NNS chemoattractants)))))))
      (VP (VBZ is)
        (NP
          (NP (NN mobilization))
          (PP (IN of)
            (NP (JJ intracellular) (NN Ca++) (NN -LSB-25))))
        (PRN (, ,)
          (NP (CD 26))
          (-RRB- -RSB-))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP
          (NP (NN contrast))
          (PP (TO to)
            (NP (NN fMLP)))))
      (, ,)
      (NP (DT the) (JJ synthetic) (NNS peptides))
      (VP (VBD had)
        (NP (DT no) (NN effect))
        (PP (IN on)
          (NP
            (NP (NN calcium) (NN mobilization))
            (PP (IN in)
              (NP (JJ human) (NNS neutrophils)))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS findings))
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the)
                (ADJP
                  (ADJP (JJ chemotactic))
                  (CC and)
                  (ADJP (JJ antiapoptotic)))
                (NNS actions))
              (PP (IN of)
                (NP (DT these) (NNS peptides))))
            (VP (VBP do) (RB not)
              (VP (VB require)
                (NP
                  (NP (NNS changes))
                  (PP (IN in)
                    (NP (JJ intracellular) (NN calcium))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (VP (VBZ is)
        (ADJP (JJ consistent)
          (PP (IN with)
            (NP
              (NP (NNS reports))
              (PP (IN of)
                (NP
                  (NP (JJ other) (JJ proinflammatory) (NNS mediators))
                  (SBAR
                    (WHNP (WDT that))
                    (S
                      (VP (VBP alter)
                        (NP
                          (NP (NN neutrophil) (NN chemotaxis))
                          (CC and)
                          (NP (NN apoptosis)))
                        (PP (IN by)
                          (NP
                            (NP (NNS mechanisms))
                            (ADJP (JJ independent)
                              (PP (IN of)
                                (NP (JJ intracellular) (NN calcium) (NNS shifts))))
                            (, ,)
                            (PP (VBG including)
                              (NP
                                (NP (NN transforming) (NN growth) (NN factor-β1))
                                (, ,)
                                (NP (JJ soluble) (NN Fas) (NN ligand))
                                (, ,)
                                (NP (JJ immune) (NNS complexes))
                                (, ,)
                                (CC and)
                                (NP
                                  (NP (DT the) (JJ antineutrophil) (NN antibody))
                                  (, ,)
                                  (NP (CD DL1.2) (NN -LSB-27))))))))))
                  (, ,) (CD 28) (, ,) (CD 29) (, ,) (CD 30) (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (NNS findings))
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN requirement))
              (PP (IN for)
                (NP
                  (NP (NNS increases))
                  (PP (IN in)
                    (NP (JJ intracellular) (NN calcium)))))
              (PP (IN for)
                (NP
                  (NP (NN induction))
                  (PP (IN of)
                    (NP (JJ biological) (NN activity))))))
            (VP (VBZ depends)
              (PP (IN on)
                (NP (DT the) (NN chemoattractant))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Activation))
        (PP (IN of)
          (NP (NN protein) (NNS kinases)))
        (PP (VBG including)
          (NP
            (NP (NN PI3-K))
            (CC and)
            (NP (NN p38) (NN MAP) (NN kinase)))))
      (VP (VBZ is)
        (VP (VBN thought)
          (S
            (VP (TO to)
              (VP (VB play)
                (NP (DT a) (JJ critical) (NN role))
                (PP (IN in)
                  (NP
                    (NP (JJ chemoattractant-induced) (NN signaling))
                    (VP (VBG leading)
                      (PP (TO to)
                        (NP
                          (NP (JJ biologic) (NNS responses))
                          (PRN
                            (QP (CD -LSB-19) (, ,) (CD 20) (, ,) (CD 31) (, ,) (CD 32) (, ,) (CD 33) (, ,) (CD 34) (, ,) (CD 35) (, ,) (CD 36))
                            (-RRB- -RSB-)))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (ADJP (JJ Consistent)
          (PP (IN with)
            (NP (DT this) (NN idea)))))
      (, ,)
      (NP (PRP we))
      (VP (VBD found)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NNS effects))
              (PP (IN of)
                (NP (DT the) (JJ synthetic) (NNS peptides)))
              (PP (IN on)
                (NP
                  (NP (NN chemotaxis))
                  (CC and)
                  (NP (NN apoptosis)))))
            (VP (VBD were)
              (ADJP (JJ dependent)
                (PP (IN on)
                  (NP (CC both)
                    (NP (NN PI3-K))
                    (CC and)
                    (NP
                      (NP (NN p38) (NN MAP) (NN kinase))
                      (NN activity))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (, ,)
      (NP
        (NP (NN LY) (CD 294002))
        (CC and)
        (NP
          (NP (NN SB) (CD 203580))
          (, ,)
          (NP
            (NP (NNS inhibitors))
            (PP (IN of)
              (NP
                (NP (NN PI3-K))
                (CC and)
                (NP (NN p38) (NN MAP) (NN kinase))
                (, ,)
                (ADVP (RB respectively)))))
          (, ,)))
      (VP (VBD blocked)
        (NP
          (NP (CC both)
            (DT the)
            (ADJP
              (ADJP (JJ chemotactic))
              (CC and)
              (ADJP (JJ antiapoptotic)))
            (NN activity))
          (PP (IN of)
            (NP
              (NP (DT each))
              (PP (IN of)
                (NP (DT the) (NNS peptides))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (SBAR (IN whereas)
        (S
          (NP
            (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5))
            (CC and)
            (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10)))
          (VP (VBD induced)
            (NP
              (NP
                (NP
                  (NP (NN PI3-K))
                  (CC and)
                  (NP (NN phospho-p38)))
                (NN expression))
              (PP (IN in)
                (NP (NNS neutrophils)))))))
      (, ,)
      (NP
        (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 5))
        (CC and)
        (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 10)))
      (VP (VBD had)
        (NP (DT no) (NN effect))
        (PP (IN on)
          (NP (DT these) (NNS proteins)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Peptides))
        (VP (VBG containing)
          (NP (NN Hyp))))
      (VP (VBD were)
        (ADVP (RB also))
        (NP (JJR less) (JJ potent) (NNS chemoattractants))
        (PP (IN than)
          (NP
            (NP (NNS peptides))
            (VP (VBG containing)
              (NP (RB only)
                (NP (NN Pro))
                (CC and)
                (NP (NNP Gly))))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS findings))
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (JJ relative) (JJ chemotactic) (NN potency))
              (PP (IN of)
                (NP (DT these) (NNS peptides))))
            (VP (MD may)
              (VP (VB be)
                (ADJP (JJ related)
                  (PP (TO to)
                    (NP
                      (NP (PRP$ their) (NN efficacy))
                      (PP (IN in)
                        (S
                          (VP (VBG upregulating)
                            (NP
                              (NP (NN PI3-K))
                              (CC and)
                              (NP (NN p38) (NN MAP) (NN kinase)))))))))))))))
    (. .)))

(
  (S
    (ADVP (RB Alternatively))
    (, ,)
    (NP
      (NP (NN fMLP))
      (, ,)
      (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5))
      (, ,)
      (CC and)
      (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10)))
    (VP (MD may)
      (VP (VB induce)
        (NP
          (NP (JJ rapid) (NNS alterations))
          (PP (IN in)
            (NP
              (NP (DT the) (JJ subcellular) (NN localization))
              (PP (IN of)
                (NP (NN PI3-K) (NN protein)))
              (PP (IN in)
                (NP (NNS neutrophils)))))))
      (, ,)
      (S
        (VP (VBG leading)
          (PP (TO to)
            (NP
              (NP (VBN increased)
                (NP (NN accessibility))
                (CC and)
                (NP (NN detection)))
              (PP (IN by)
                (NP (NN immunoblotting))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN contrast)))
      (, ,)
      (NP (DT this))
      (VP (VBZ does) (RB not)
        (VP (VB appear)
          (S
            (VP (TO to)
              (VP (VB be)
                (NP
                  (NP (DT the) (NN case))
                  (PP (IN for)
                    (NP (NN apoptosis))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (, ,)
      (NP
        (NP (DT an) (NN inability))
        (VP (TO to)
          (VP (VB induce)
            (NP
              (NP (NN PI3-K))
              (CC or)
              (NP (NN phospho-p38))
              (NP (NN MAP) (NN kinase))))))
      (VP (VBD had)
        (NP (DT no) (NN effect))
        (PP (IN on)
          (NP
            (NP (DT the) (JJ antiapoptotic) (NN activity))
            (PP (IN of)
              (NP (JJ Hyp-containing) (NNS peptides)))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN observation)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (JJ antiapoptotic) (NNS effects))
              (PP (IN of)
                (NP
                  (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 5))
                  (CC and)
                  (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 10)))))
            (VP (VBD were)
              (VP (VBN blocked)
                (PP (IN by)
                  (NP
                    (NP (NN PI3-K))
                    (CC and)
                    (NP (NN p38))
                    (NP (NN MAP) (NN kinase) (NNS inhibitors)))))))))
      (VP (VBZ indicates)
        (SBAR (IN that)
          (S
            (NP (DT these) (NN signaling) (NNS pathways))
            (VP (VBP are)
              (ADVP (RB nevertheless))
              (ADJP (JJ essential)
                (PP (IN for)
                  (NP (DT this) (NN response)))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP (PRP they))
      (VP (VBP appear)
        (S
          (VP (TO to)
            (VP (VB be)
              (VP (VBN activated)
                (ADVP (RB distinctly))
                (PP (IN by)
                  (NP
                    (NP
                      (PRN (-LRB- -LRB-)
                        (NP (NN Pro-Pro-Gly))
                        (-RRB- -RRB-))
                      (NN n))
                    (CC and)
                    (NP
                      (PRN (-LRB- -LRB-)
                        (NP (NN Pro-Hyp-Gly))
                        (-RRB- -RRB-))
                      (NN n))
                    (NP (NNS peptides))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Previous) (NNS studies))
      (VP (VBP have)
        (VP (VBN suggested)
          (SBAR (IN that)
            (S
              (NP
                (NP (JJ PI3-K-mediated) (NNS responses))
                (VP (VBN induced)
                  (PP (IN by)
                    (NP (NNS chemoattractants)))))
              (VP (VBP involve)
                (NP
                  (NP (NN mobilization))
                  (PP (IN of)
                    (NP (JJ intracellular) (NN calcium))))
                (PP (IN through)
                  (NP
                    (NP (NN activation))
                    (PP (IN of)
                      (NP (NN phospholipase) (NN C) (CD -LSB-37))))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Alterations))
        (PP (IN in)
          (NP (JJ cytosolic) (NN Ca2+))))
      (VP (VBP are)
        (ADVP (RB also))
        (ADJP (JJ important)
          (PP (IN in)
            (S
              (VP (VBG inducing)
                (NP
                  (NP (NN p38) (NN MAP) (NN kinase))
                  (NN activity))
                (PP (IN in)
                  (NP (NNS neutrophils) (CD -LSB-38) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN contrast)))
      (, ,)
      (NP (PRP$ our) (NNS findings))
      (VP (VBP indicate)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ synthetic) (JJ peptide-induced) (NN activation))
              (PP (IN of)
                (NP
                  (NP (NN PI3-K))
                  (CC and)
                  (NP (NN p38) (NN MAP) (NN kinase))))
              (, ,)
              (VP (VBG leading)
                (PP (TO to)
                  (NP
                    (NP (NN chemotaxis))
                    (CC and)
                    (NP (VBN reduced) (NN apoptosis)))))
              (, ,))
            (VP (VBZ occurs)
              (PP (IN though)
                (NP (JJ calcium-independent) (NNS pathways))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ is)
        (ADJP (JJ possible))
        (SBAR (IN that)
          (S
            (NP
              (NP (NNS phosphoinositides))
              (, ,)
              (CC or)
              (NP
                (NP (VBN phosphorylated) (NN protein) (NNS products))
                (PP (IN of)
                  (NP
                    (NP (NN PI3-K))
                    (CC or)
                    (NP (NN p38) (NN MAP) (NN kinase)))))
              (, ,))
            (VP (VBP interact)
              (ADVP (RB directly))
              (PP (IN with)
                (NP (JJ actin-binding) (NNS proteins)))
              (, ,)
              (S
                (VP (VBG resulting)
                  (PP (IN in)
                    (NP
                      (NP (JJ directed) (NN migration))
                      (PP (IN of)
                        (NP (DT the) (NNS cells)))))
                  (NP (CD -LSB-39))
                  (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (NP (NN p38) (NN MAP) (NN kinase))
      (VP (VBZ is)
        (ADVP (RB also))
        (VP (VBN known)
          (S
            (VP (TO to)
              (VP (VB phosphorylate)
                (NP
                  (NP (NNS proteins))
                  (SBAR
                    (WHNP (WDT that))
                    (S
                      (VP (MD may)
                        (VP (VB regulate)
                          (NP
                            (NP (NN chemotaxis))
                            (CC and)
                            (NP (NN apoptosis)))
                          (PP (IN by)
                            (NP
                              (NP (JJ calcium-independent) (NNS mechanisms))
                              (, ,)
                              (PP (VBG including)
                                (NP
                                  (NP (NN MAP) (JJ kinase-activated) (NNS proteins))
                                  (QP (CD 2) (, ,) (CD 3) (, ,)
                                    (CC and)
                                    (CD 5))))
                              (, ,)
                              (CONJP (RB as) (RB well) (IN as))
                              (NP (DT the) (NN transcription) (NNS factors)
                                (NP
                                  (NP (NN ATF-2))
                                  (CC and)
                                  (NP (NN CHOP-1) (CD -LSB-40) (-RRB- -RSB-)))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Signaling))
        (PP (IN via)
          (NP
            (NP (NN PI3-K))
            (CC and)
            (NP (NN p38) (NN MAP) (NN kinase)))))
      (VP (VBZ leads)
        (PP (TO to)
          (NP
            (NP (DT the) (NN activation))
            (PP (IN of)
              (NP (DT the) (NN transcription) (NN factor) (NN NF-κB)))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (VBZ is)
                  (VP (VBN known)
                    (S
                      (VP (TO to)
                        (VP (VB regulate)
                          (NP
                            (NP (NNS genes))
                            (VP (VBN involved)
                              (PP (IN in)
                                (NP
                                  (NP (JJ inflammatory) (NNS responses))
                                  (PP (TO to)
                                    (NP (NN tissue) (NN injury) (CD -LSB-41) (-RRB- -RSB-))))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN NF-κB))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN reported)
            (S
              (VP (TO to)
                (VP (VB be)
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP
                        (NP (JJ chemoattractant-induced) (NN neutrophil) (NN activation))
                        (CONJP (RB as) (RB well) (IN as))
                        (NP
                          (NP (DT the) (NN suppression))
                          (PP (IN of)
                            (NP (NN apoptosis) (CD -LSB-22) (, ,) (CD 42))))
                        (-RRB- -RSB-)))))))))))
    (. .)))

(
  (S
    (ADVP (RB Moreover))
    (, ,)
    (S
      (S
        (NP
          (NP (NNS mice))
          (VP (VBG lacking)
            (NP (DT the) (NN NF-κB) (NN subunit) (NN c-Rel))))
        (VP (VBP are)
          (ADJP (JJ resistant)
            (PP (TO to)
              (NP (JJ collagen-induced) (NN arthritis))))))
      (, ,)
      (CC and)
      (S
        (NP
          (NP (NN inhibition))
          (PP (IN of)
            (NP (NN NF-κB))))
        (VP (VBZ blocks)
          (NP
            (NP (NN neutrophil) (NN migration))
            (PP (IN into)
              (NP (JJ damaged) (NNS lungs))))
          (ADVP (FW in) (FW vivo))
          (PRN
            (QP (CD -LSB-43) (, ,) (CD 44) (, ,) (CD 45))
            (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD found)
        (SBAR (IN that)
          (S
            (NP
              (NP (NNS peptides))
              (VP (VBG containing)
                (NP (JJ collagen-related) (JJ structural) (NNS motifs))))
            (VP (VBD induced)
              (NP (JJ NF-κB) (JJ nuclear) (NN binding) (NN activity))
              (PP (IN in)
                (NP (NNS neutrophils))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP
        (NP (DT no) (JJ significant) (NNS differences))
        (PP (IN in)
          (NP (NN activity))))
      (VP (VBD were)
        (VP (VBN observed)
          (PP (VBN based)
            (PP (IN on)
              (NP
                (NP (DT the)
                  (NP
                    (NP (NN size))
                    (CC or)
                    (NP (NN composition))))
                (PP (IN of)
                  (NP (DT the) (NNS peptides)))))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS findings))
      (VP
        (VP (VBP are)
          (ADJP (JJ consistent)
            (PP (IN with)
              (NP
                (NP (DT the) (JJ antiapoptotic) (NNS effects))
                (PP (IN of)
                  (NP (DT these) (JJ synthetic) (NNS peptides)))))))
        (CC and)
        (VP (VBP suggest)
          (SBAR (IN that)
            (S
              (NP
                (NP (DT the)
                  (ADJP
                    (ADJP (JJ chemotactic))
                    (CC and)
                    (ADJP (JJ antiapoptotic)))
                  (NNS effects))
                (PP (IN of)
                  (NP (DT the) (NNS peptides))))
              (VP (VBP involve)
                (NP
                  (NP (JJ distinct) (NN signaling) (NNS pathways))
                  (VP (VBG leading)
                    (PP (TO to)
                      (NP (JJ NF-κB) (NN activation)))))))))))
    (. .)))

(
  (S
    (NP (NNS CONCLUSIONS))))

(
  (S
    (S
      (NP
        (NP (JJ Polymeric) (NNS polypeptides))
        (VP (VBG containing)
          (NP (JJ collagen-related) (JJ structural) (NNS motifs))))
      (VP (VBP promote)
        (NP (NN inflammation))
        (PP (IN by)
          (S
            (VP
              (VP (VBG inducing)
                (NP (NN chemotaxis)))
              (CC and)
              (VP (VBG blocking)
                (NP (NN apoptosis))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP (JJ distinct) (JJ calcium-independent) (NN signaling) (NNS pathways))
      (VP (VBP appear)
        (S
          (VP (TO to)
            (VP (VB be)
              (VP (VBN involved)
                (PP (IN in)
                  (NP (DT these) (NNS activities)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Neutrophil) (NN chemotaxis))
        (CC and)
        (NP (NN apoptosis)))
      (VP (VBP are)
        (NP
          (NP (DT a) (JJ key))
          (PP (TO to)
            (S
              (VP
                (VP (VBG initiating))
                (CC and)
                (VP (VBG controlling)
                  (NP (NN inflammation)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The)
          (NP (NN accumulation))
          (CC and)
          (NP (NN persistence)))
        (PP (IN of)
          (NP (DT these) (NNS cells)))
        (PP (IN in)
          (NP
            (NP (NNS tissues))
            (PP (IN in)
              (NP
                (NP (NN response))
                (PP (TO to)
                  (NP
                    (NP (NN protein) (NNS fragments))
                    (VP (VBN generated)
                      (PP
                        (PP (IN by)
                          (NP (JJ invasive) (NNS pathogens)))
                        (CC or)
                        (PP (IN by)
                          (NP
                            (NP (DT the) (NN degradation))
                            (PP (IN of)
                              (NP (JJ connective) (NN tissue) (NN collagen))))))))))))))
      (VP (MD may)
        (VP (VB exacerbate)
          (NP (NN injury)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT An) (NN understanding))
        (PP (IN of)
          (NP
            (NP (DT the) (NNS mechanisms))
            (VP (VBG mediating)
              (NP (DT these) (NNS processes))))))
      (VP (VBZ is)
        (ADJP (JJ essential)
          (PP (IN in)
            (S
              (VP (VBG developing)
                (NP
                  (NP (NNS strategies))
                  (PP (IN for)
                    (S
                      (VP (VBG limiting)
                        (NP (JJ maladaptive) (JJ inflammatory) (NNS responses))))))))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure))
      (CC and)
      (NP (NN Table))
      (NP (NNS captions)))))

(
  (S
    (NP
      (NP (NN Figure) (CD 1) (: :) (NN Induction))
      (PP (IN of)
        (NP (NN chemotaxis)))
      (PP (IN by)
        (NP (JJ synthetic))))))

(
  (S
    (NP
      (NP (NNS polypeptides))
      (. .))))

(
  (S
    (NP (NN Neutrophil) (NN chemotaxis))
    (VP (VBD was)
      (VP (VBN assayed)
        (S
          (VP (VBG using)
            (NP (NN microwell))))))))

(
  (S
    (NP
      (NP (NNS chambers))
      (. .))))

(
  (S
    (NP (DT Each) (NN bar))
    (VP (VBZ represents)
      (NP
        (NP (DT the) (NN mean) (NN ±) (NN SEM))
        (PP (IN of)
          (NP (NN 3–4)))))))

(
  (S
    (NP
      (NP (NNS experiments))
      (. .))))

(
  (S
    (NP
      (NP (NN Background) (NNS levels))
      (PP (IN of)
        (NP (NN migration))))
    (VP (VBD were)
      (VP (VBN subtracted)
        (PP (IN from))))))

(
  (S
    (S
      (NP (DT each) (NN value)))
    (. .)))

(
  (S
    (NP
      (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-))
      (NP (JJ Dose-dependent) (NNS effects))
      (PP (IN of)
        (NP (NNS peptides)))
      (PP (IN on)
        (NP (NN neutrophil))))))

(
  (S
    (NP
      (NP (NN chemotaxis))
      (. .))))

(
  (S
    (S
      (NP (-LRB- -LRB-) (NN b) (-RRB- -RRB-) (NNS Cells))
      (VP (VBD were)
        (VP (VBN incubated)
          (PP (IN with)
            (NP (NN medium) (NN control))))))
    (, ,)
    (NP (DT the) (NN p38))))

(
  (S
    (NP
      (NP
        (NP
          (NP (NN MAP) (NN kinase) (NN inhibitor))
          (NP (NN SB) (CD 203580)))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (NN 30 μM))
            (, ,)
            (NP (NN 1 hour)))
          (-RRB- -RRB-)))
      (CC or)
      (NP (DT the)))))

(
  (S
    (NP
      (NP (NN PI3-K) (NN inhibitor))
      (NP
        (NP
          (NP (NN LY) (NN 294002))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NN 50 μM))
              (, ,)
              (NP (NN 5 minutes)))
            (-RRB- -RRB-)))
        (ADJP (JJ prior)
          (PP (TO to)))))))

(
  (S
    (NP
      (NP (DT the) (NN analysis))
      (PP (IN of)
        (NP
          (NP (JJ chemotactic) (NN responsiveness))
          (PP (TO to)
            (NP (NNS polypeptides))))))))

(
  (S
    (S
      (PRN (-LRB- -LRB-)
        (NP (NN 10 nM))
        (-RRB- -RRB-)))
    (. .)))

(
  (S
    (NP
      (NP
        (PRN (-LRB- -LRB-)
          (NP (NN Pro-Pro-Gly))
          (-RRB- -RRB-))
        (NP (NN n)))
      (, ,)
      (NP
        (NP (-LRB- -LRB-) (NN PPG) (-RRB- -RRB-) (NN n))
        (: ;)))))

(
  (S
    (S
      (NP
        (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (NN n) (, ,))
        (PRN (-LRB- -LRB-)
          (NP (NN POG))
          (-RRB- -RRB-)))
      (NP (NN n)))
    (. .)))

(
  (S
    (S
      (NP (NN Figure) (CD 2))
      (: :)
      (NP
        (NP (NN Measurement))
        (PP (IN of)
          (NP (NN neutrophil) (NN apoptosis)))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Cells))
      (VP (VBD were)))))

(
  (S
    (VP (VBN incubated)
      (PP (IN in)
        (NP
          (NP (DT a) (JJ shaking) (NN water) (NN bath))
          (PRN (-LRB- -LRB-)
            (NP (NN 37°C))
            (-RRB- -RRB-))))
      (PP (IN in)
        (NP (DT the) (NN presence) (NN or))))))

(
  (S
    (NP
      (NP (NN absence))
      (PP (IN of)
        (NP (NN fMLP)))
      (PRN (-LRB- -LRB-)
        (NP (CD 5) (NN ×) (NN 10−8 M))
        (-RRB- -RRB-))
      (, ,)
      (NP (JJ synthetic)))))

(
  (S
    (NP
      (NP
        (NP (NNS polypeptides))
        (, ,)
        (NP (NN SB) (CD 203580))
        (, ,)
        (CC or)
        (NP (NN LY) (CD 294002)))
      (UCP
        (PP (IN for)
          (NP (NNS 24 hours)))
        (CC and)
        (ADVP (RB then))))))

(
  (S
    (VP
      (VP (VBN labeled)
        (PP (IN with)
          (NP
            (NP (NN Annexin) (NN V))
            (CC and)
            (NP (NN propidium) (NN iodide)))))
      (CC and)
      (VP (VBN analyzed)
        (PP (IN by)
          (NP (NN flow)))))))

(
  (S
    (NP
      (NP (NN cytometry))
      (. .))))

(
  (S
    (NP (NNS Data))
    (VP (VBD were)
      (VP (VBN analyzed)
        (S
          (VP (VBG using)
            (NP (NN Coulter) (NN quadrant) (NNS statistics))))))))

(
  (S
    (VP (VBN based)
      (PP (IN on)
        (NP
          (NP (JJ relative) (NN fluorescence) (NN binding))
          (PP (IN of)
            (NP
              (NP (NN Annexin) (NN V))
              (CC and)
              (NP (NN propidium)))))))))

(
  (S
    (NP
      (NP (NN iodide))
      (. .))))

(
  (S
    (NP (DT Each) (NN bar))
    (VP (VBZ represents)
      (NP
        (NP (DT the) (NN mean) (NN ±) (NN SEM))
        (PP (IN of)
          (NP (NN 3–4)))))))

(
  (S
    (NP
      (NP (NNS experiments))
      (. .))))

(
  (S
    (NP
      (NP
        (ADJP (RB Significantly) (JJ different)))
      (PRN (-LRB- -LRB-)
        (NP (NN P) (NN <) (CD .05))
        (-RRB- -RRB-)))))

(
  (S (IN from)))

(
  (S
    (NP
      (NP (NN control))
      (. .))))

(
  (S
    (NP
      (NP (NN Figure) (CD 3))
      (: :)
      (NP
        (NP (NNS Effects))
        (PP (IN of)
          (NP (JJ synthetic) (NNS polypeptides)))
        (PP (IN on)
          (NP (NN calcium)))))))

(
  (S
    (NP
      (NP (NN mobilization))
      (. .))))

(
  (S
    (NP (NNS Neutrophils))
    (VP (VBD were)
      (VP (VBN incubated)
        (PP (IN with)
          (NP (NN Indo-1)))))))

(
  (S
    (S
      (PRN (-LRB- -LRB-)
        (NP (NN 1 μM))
        (-RRB- -RRB-)))
    (. .)))

(
  (S
    (PP (IN After)
      (S
        (VP (VBG establishing)
          (NP (DT a) (JJ stable) (NN baseline)))))
    (, ,)
    (NP (NN 10 nM))))

(
  (S
    (NP
      (NP
        (NP
          (NP
            (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5))
            (, ,)
            (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10))
            (, ,))
          (PRN (-LRB- -LRB-)
            (NP (NN Pro-Hyp-Gly))
            (-RRB- -RRB-)))
        (CD 5))
      (, ,)
      (NP (NN or)))))

(
  (S
    (S
      (NP (NN fMLP))
      (VP (VBD was)
        (VP (VBN added)
          (PRN (-LRB- -LRB-)
            (NP (NN arrow))
            (-RRB- -RRB-))
          (PP (TO to)
            (NP (DT the) (NNS cells))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Calcium) (NN mobilization))
      (VBZ is))))

(
  (S
    (S
      (VP (VBN indicated)
        (PP (IN by)
          (NP
            (NP (DT an) (NN increase))
            (PP (IN in)
              (NP (DT the) (JJ Indo-1) (NN fluorescence) (NN ratio)))))))
    (. .)))

(
  (S
    (NP (DT Each))))

(
  (S
    (NP (NN graph))
    (VP (VBZ represents)
      (NP
        (NP (DT the) (JJ average) (NN change))
        (PP (IN in)
          (NP (NN ratio)))
        (PP (IN in)
          (NP
            (NP (DT a) (NN field))
            (VP (VBG containing))))))))

(
  (S
    (S
      (NP
        (QP (RB not) (JJR less) (IN than) (CD 15))
        (NNS cells)))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure) (CD 4))
      (: :)
      (NP
        (NP (NNS Effects))
        (PP (IN of)
          (NP (JJ synthetic) (NNS polypeptides)))
        (PP (IN on)
          (NP
            (NP (NN PI3-K))
            (CC and)
            (NP (NN p38))
            (NP (NN MAP))))))))

(
  (S
    (NP
      (NP (NN kinase) (NN expression))
      (. .))))

(
  (S
    (NP (NNS Neutrophils))
    (VP (VBD were)
      (VP (VBN incubated)
        (PRN (-LRB- -LRB-)
          (NP (NN 37°C))
          (-RRB- -RRB-))
        (PP (IN with))))))

(
  (S
    (NP
      (NP (NN medium) (NN control))
      (, ,)
      (NP
        (NP (NN fMLP))
        (PRN (-LRB- -LRB-)
          (NP (CD 5) (NN ×) (NN 10−8 M))
          (-RRB- -RRB-)))
      (, ,)
      (CC or)
      (NP (NN 10 nM)))))

(
  (S
    (NP
      (NP
        (NP
          (NP
            (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5))
            (, ,)
            (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10))
            (, ,))
          (PRN (-LRB- -LRB-)
            (NP (NN Pro-Hyp-Gly))
            (-RRB- -RRB-)))
        (CD 5))
      (, ,)
      (NP (NN or)))))

(
  (S
    (NP
      (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 10))
      (PP (IN for)
        (NP
          (NP
            (NP (NNS 2 hours))
            (PRN (-LRB- -LRB-)
              (NP (NN PI3-K))
              (-RRB- -RRB-)))
          (CC or)
          (NP (NNS 5 minutes)))))))

(
  (S
    (S
      (PRN (-LRB- -LRB-)
        (NP
          (NP (NN p38))
          (, ,)
          (NP (NN phospho-p38)))
        (-RRB- -RRB-)))
    (. .)))

(
  (S
    (NP
      (NP (-LRB- -LRB-) (DT a) (-RRB- -RRB-)
        (NP
          (NP (NN PI3-K))
          (, ,)
          (NP (-LRB- -LRB-) (NN b) (-RRB- -RRB-) (NN p38))
          (, ,))
        (-LRB- -LRB-) (NN c) (-RRB- -RRB-) (NN phospho-p38) (, ,))
      (PRN (-LRB- -LRB-)
        (NP (NN d))
        (-RRB- -RRB-)))))

(
  (S
    (NP (NN protein) (NNS expressions))
    (VP (VBD were)
      (VP (VBN measured)
        (S
          (VP (VBG using)
            (NP (NN western) (NN blotting))))))))

(
  (S
    (S (CC and)
      (VP (VBN quantified)
        (PP (IN by)
          (NP (NN densitometry)))))
    (. .)))

(
  (S
    (NP
      (NP (NN Time) (NN course))
      (PP (IN of)
        (NP (NN phospho-p38) (NN protein))))))

(
  (S
    (NP
      (NP (NN expression))
      (PP (IN in) (NN response) (TO to)
        (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5)))
      (. .))))

(
  (S
    (NP
      (NP (NN Western) (NNS blots))
      (VP (VBD were)))))

(
  (S
    (VP (VBN scanned)
      (PP (IN by)
        (NP
          (NP (NN densitometry))
          (CC and)
          (NP
            (NP (NNS data))
            (VP (VBN presented)
              (PP (IN as)
                (NP (JJ relative) (NN intensity))))))))))

(
  (S
    (NP
      (NP (NNS units))
      (. .))))

(
  (S
    (NP
      (NP (CD One) (JJ representative) (NN experiment))
      (PP (IN of)
        (NP (CD 3))))
    (VP (VBZ is)
      (VP (VBN shown)
        (PP (IN for)
          (NP (DT each)))))))

(
  (S
    (NP
      (NP (NN analysis))
      (. .))))

(
  (S
    (NP
      (NP (NN Figure) (CD 5))
      (: :)
      (NP
        (NP (NNS Effects))
        (PP (IN of)
          (NP (JJ synthetic) (NNS polypeptides)))
        (PP (IN on)
          (NP (NN NF-κB)))))))

(
  (S
    (S
      (NP (JJ nuclear) (NN binding) (NN activity)))
    (. .)))

(
  (S
    (NP
      (NP
        (NP (NNS Neutrophils))
        (PRN (-LRB- -LRB-)
          (NP (CD 1) (NN ×) (NN 106/mL))
          (-RRB- -RRB-)))
      (VP (VBD were)))))

(
  (S
    (S
      (VP (VBN treated)
        (PP (IN with)
          (NP (NN medium) (NN control)))
        (PRN (-LRB- -LRB-)
          (NP (NNP Med))
          (-RRB- -RRB-))))
    (, ,)
    (NP (JJ synthetic) (NNS peptides))))

(
  (S
    (NP
      (NP (-LRB- -LRB-) (NN 10 nM) (-RRB- -RRB-))
      (, ,)
      (CC or)
      (NP
        (NP
          (NP (NN fMLP))
          (PRN (-LRB- -LRB-)
            (NP (CD 5) (NN ×) (NN 10−8 M))
            (-RRB- -RRB-)))
        (PP (IN for))))))

(
  (S
    (NP
      (NP (NN 30 minutes))
      (. .))))

(
  (S
    (NP
      (NP
        (NP (JJ Nuclear) (NNS extracts))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (NN 50 μg))
            (PP (IN of)
              (NP (NN protein))))
          (-RRB- -RRB-)))
      (VP (VBD were)))))

(
  (S
    (S
      (VP (VBN analyzed)
        (PP (IN for)
          (NP (JJ NF-κB) (NN binding) (NN activity)))))
    (S
      (VP (VBG using)
        (NP (DT a) (NN gel) (NN retardation))))))

(
  (S
    (NP
      (NP (NN assay))
      (. .))))

(
  (S
    (NP
      (NP (NNS Extracts))
      (, ,)
      (VP (VBN prepared)
        (PP (IN from)
          (NP (JJ fMLP-treated) (NNS cells)))))
    (VP (VBD were)
      (VP (VBN incubated)))))

(
  (S
    (NP
      (NP (NN in) (NN ice))
      (PP (IN for)
        (NP (NN 1 hour)))
      (PP (IN with)
        (NP
          (NP (NNS antibodies))
          (PP (TO to)
            (NP (DT the)
              (NP
                (NP (NN p50))
                (CC or)
                (NP (NN p65))))))))))

(
  (S
    (NP
      (NP
        (NP (NNS subunits))
        (PP (IN of)
          (NP
            (NP (NN NF-κB))
            (PRN (-LRB- -LRB-)
              (NP (NN 1 μg))
              (-RRB- -RRB-)))))
      (, ,)
      (CC or)
      (NP (RB 100-fold)
        (NP (NN excess))))))

(
  (S
    (NP
      (NP
        (NP (JJ unlabeled) (JJ cold) (NN competitor))
        (PRN (-LRB- -LRB-)
          (NP (NN Comp))
          (-RRB- -RRB-)))
      (ADJP (JJ prior)
        (PP (TO to)
          (NP (DT the) (JJ labeled)))))))

(
  (S
    (NP
      (NP (NN probe))
      (. .))))

